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Abstract
This thesis explored the extent to which adolescents and young adults (AYAs) with
childhood-onset epilepsy experience epilepsy worry 10 years after diagnosis and its
association with AYAs’ clinical, demographic, and family characteristics. It also explored the
extent to which epilepsy worry correlates with anxiety and depression. Data were derived
from the Health-Related Quality of Life in Children with Epilepsy Study, a multicenter
prospective cohort study that followed children with newly-diagnosed epilepsy for 10 years
after diagnosis. At the 10-year follow-up, about 40% of 130 AYAs had experienced at least
some epilepsy worry within the past four weeks. A binomial-gamma hurdle model found
that 5-year seizure freedom status and current anti-epileptic drug treatment were
associated with epilepsy worry. Epilepsy worry was weakly and moderately correlated with
anxiety and depression, respectively. These findings highlight epilepsy worry as a potential
distinct intervention target for improving the mental health of AYAs with childhood-onset
epilepsy.

Keywords
Childhood-onset epilepsy, disease-specific mental health, worry, epilepsy worry,
adolescents, young adults, longitudinal study.
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Summary for Lay Audience
The unpredictable nature of seizures in epilepsy may provoke epilepsy worry—a state of
worry specific to future seizures and their consequences that could influence the mental
health of people with epilepsy. The aims of this thesis were to assess the extent to which
adolescents and young adults (AYAs) experience epilepsy worry 10 years after their epilepsy
diagnosis in childhood, and to identify possible risk factors for epilepsy worry. This thesis
also assessed the extent to which AYAs’ epilepsy worry correlates with anxiety and
depression. Data for this thesis were derived from the Health-Related Quality of Life in
Children with Epilepsy Study, a multicenter prospective cohort study that followed children
with newly-diagnosed epilepsy for 10 years after diagnosis. While the majority of the 130
AYAs studied were not experiencing epilepsy worry, which is consistent with the generally
favourable long-term seizure outcome for childhood-onset epilepsy, about 40% of these
AYAs had experienced at least some epilepsy worry within the past four weeks. AYAs who
had not achieved seizure freedom and those who were currently taking anti-epileptic drugs
have higher odds of experiencing any epilepsy worry, and AYAs who were currently taking
anti-epileptic drugs were more likely to experience higher levels of epilepsy worry. Anxiety
was found to be weakly correlated with epilepsy worry, while depression was moderately
correlated with epilepsy worry. This means that epilepsy worry is related to anxiety and
depression but is partially distinct. These findings suggest that epilepsy worry should be
examined as its own aspect of mental health in people with epilepsy, both in research and
in clinical practices. More research is needed to understand the relationship between antiepileptic drugs and epilepsy worry. Healthcare professionals could consider screening AYAs
in remission to identify those who still experience epilepsy worry and offer reassurance to
reduce their worry.
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Chapter 1

1

Introduction

Epilepsy is a neurological disease with its most defining feature being recurrent and
unprovoked seizures. Seizures are unpredictable in nature, and the severity can range
from a brief loss of consciousness—absence seizures—to generalized tonicclonic seizures where the loss of consciousness is followed by strong tonic muscle
spasms and intense jerking movements. The consequences of having seizures, the side
effects of having treatments for seizures, and conditions that are co-morbid with
epilepsy can all impose challenges on an individual’s life, from influencing school or
work and placing restrictions on recreation or social life, to adding strains on family
relationships. Due to the unpredictability of seizures, it is understandable that
individuals with epilepsy tend to worry about the occurrence of future seizures, referred
to as epilepsy worry. Worry is a natural response to anticipated future problems, and
excessive worrying can negatively influence an individual’s emotional and physical
health. When it comes to worrying about epilepsy, excessive worrying can place
additional emotional burden on an individual’s attempt to cope with the condition and
further restrict their lives and activities.
As with other emotions, how much a person worries about their epilepsy and seizures
can be influenced by a wide range of factors. Clinical characteristics such as when the
person last experienced a seizure or the severity of the person’s seizures are likely to
have an influence on epilepsy worry. Demographic characteristics (e.g., the person’s
sex) or family characteristics (e.g., the amount of resources available to families to help
with adaptation to stressful life events) could also contribute to the person’s extent of
worry. Understanding the extent to which people with epilepsy experience epilepsy
worry and the relationship between epilepsy worry and the possible influencing factors
could help identify a subgroup of individuals who are at increased risk of epilepsy worry
and inform efforts to develop effective interventions to address their worry.
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The aims of this thesis were to assess the extent to which people with childhood-onset
epilepsy, specifically adolescents and young adults (AYAs), experience epilepsy worry,
and to assess the relationship between epilepsy worry and AYAs’ clinical, demographic,
and family characteristics. Chapter 2 provides a more detailed review of the literature
on epilepsy and an overview on the current state of knowledge regarding epilepsy
worry. Chapter 3 presents the specific objectives for the thesis, and introduces the
conceptual framework used to guide the data analysis in this thesis. Chapter 4 provides
details of the methodology used in this thesis, including the source of data,
measurement of variables, and data analysis plans. Chapter 5 presents the study
findings, and Chapter 6 summarizes and discusses the study results.
The data analyzed in this thesis arose from the Health-Related Quality of Life in Children
with Epilepsy Study (HERQULES), described in more detail in Chapter 3.
My role in the study included: Developing research objectives for this thesis, conducting
a literature review pertaining to the thesis objectives, conducting statistical analysis
under the supervision of my thesis committee, and creating summary reports of the
study findings and making conclusions based on the findings.
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Chapter 2

2

Background

This chapter provides background information about epilepsy and epilepsy worry, which
motivated this thesis. Section 2.1 provides a broad picture on epilepsy and its
epidemiology, followed by an overview of worry as an emotion and the literature on
epilepsy worry in section 2.2. Section 2.3 discusses the impact of a child’s epilepsy on
the family and the potential influence of parent’s worry on child’s health. The chapter
finishes with a summary of the limitations of past studies on epilepsy worry in section
2.4.

2.1 Epilepsy
Epilepsy is a neurological disease of the brain with a predisposition to generate
recurrent seizures. According to the most recent definition of epilepsy provided by the
International League Against Epilepsy (ILAE) in 2014, a person is considered to have
epilepsy if any of the following three conditions are met (1):
1. “At least two unprovoked (or reflex) seizures occurring >24 h apart,” or
2. “One unprovoked (or reflex) seizure and a probability of further seizures similar
to the general recurrence risk (at least 60%) after two unprovoked seizures,
occurring over the next 10 years,” or
3. “Diagnosis of an epilepsy syndrome,” which could occur even if the risk of
subsequent seizures are low, as long as specific features for the syndrome, such
as the age when seizure begin, seizure types, and EEG findings, are present.
For people with epilepsy, the ideal outcome is to be free of seizures without being
dependent on medication. Based on the recently adopted definition of epilepsy
resolution, epilepsy is considered to be resolved when an individual with an agedependent epilepsy syndrome has past the age range for the syndrome, or if the
individual has been seizure-free for at least 10 years without using anti-seizure
medications for at least the most recent 5 years (1).
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The primary method of treatment for epilepsy is anti-epileptic drugs (AEDs).
Unfortunately, approximately a third of people with epilepsy do not respond to AEDs
and continue to experience seizures (2). Alternative treatment options are available for
these people with drug-resistant epilepsy (DRE), including dietary modifications
(ketogenic diet, modified Atkins diet, or low glycemic diet), vagal nerve stimulation, and
surgical intervention.

2.1.1

Epilepsy in Children

Epilepsy is the most common neurological condition in children. According to a recent
review article summarizing the incidence and prevalence of epilepsy in children around
the world (3), the incidence of epilepsy in children is 41 to 187 per 100,000 per year
with a higher incidence in low and middle income countries. Incidence is highest during
the first year of life and gradually declines to a level similar to that of adults by
approximately 10 years of age. The prevalence of epilepsy in children is estimated to be
3.2 to 5.5 per 1,000 in high income countries and 3.6 to 44 per 1,000 in low and middle
income countries (3). In Canada, the prevalence of epilepsy in children (birth to 15 years
of age) is estimated to be 2.3 to 5.3 per 1000 (4).
The long-term seizure outcome for childhood-onset epilepsy is generally favourable, and
approximately two-thirds of childhood-onset epilepsies will enter 5-year terminal
remission (5–7). However, there is a possibility of relapse even after having a long
period of remission, and some of these relapses may become intractable (5,6). Although
the possibility of relapse after seizure remission is low, a guarantee of permanent
seizure-free status cannot be made.

2.1.2

Comorbidity

Epilepsy involves more than just recurrent seizures. The ILAE and the International
Bureau for Epilepsy (IBE) define epilepsy as a condition that is also characterized by its
neurobiological, cognitive, psychological, and social consequences (8). A number of
studies have been conducted to evaluate the risk of comorbidities in children with
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epilepsy compared to the general population or children with other chronic conditions.
A national survey from the United States reported that children with active epilepsy are
at significantly higher risk of psychological and developmental comorbidities, when
compared to children who have never been diagnosed with epilepsy (9). These
comorbidities include depression, anxiety, attention deficit hyperactivity disorder
(ADHD), developmental delay, and autism spectrum disorder (ASD). Children with
epilepsy also demonstrate poorer social competence and more academic difficulties
compared to those without epilepsy (9). The same survey found that children who had a
previous diagnosis of epilepsy but who were not having seizures currently had
intermediate levels of risk for these comorbidities and difficulties (9). In a nationwide
study in Norway, 78% of children with epilepsy (birth to 17 years) had at least one
comorbid disorder (either medical, neurological, developmental, or psychiatric) on
record, compared to only 30% of children in the general population (10). When focusing
on developmental and psychiatric disorders, these conditions were reported in 43% of
children with epilepsy, compared to only 7% in the general population (10). This
increased risk of psychiatric disorders was also found in a nationwide survey in Britain,
where children with epilepsy aged 5 to 15 years had a prevalence of psychiatric
disorders (37%) that was much higher compared to those with diabetes (11%) or
controls (9%) (11).
Comorbid conditions associated with epilepsy are increasingly recognized as important
factors for long-term psychosocial outcomes. These comorbid conditions may share
causes or risk factors with epilepsy, be the causes of epilepsy, or are the consequence of
seizures or anti-epileptic treatment. Comorbid conditions in a large proportion of
children with epilepsy impose significant impacts on both the children and society. They
interfere with social, cognitive, and psychological development in children with epilepsy,
and have been found to influence their quality of life (QoL) more than seizure-related
characteristics like remission status and severity of epilepsy (12). Furthermore, having
psychiatric and developmental comorbidities increases the utilization of health
resources—including outpatient neurology visits, emergency department visits, and
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hospitalizations—among children with epilepsy, and the risk of such costly utilization
increases with the number of comorbidities (13). Although psychiatric comorbidities
require attention and adequate management, the need for mental health services in
children with epilepsy is often unmet (14). These unmet needs occur more frequently in
these children compared to those without a diagnosis of epilepsy (9), and continue to be
experienced two years after the child’s first seizure (15). Such unmet needs can
exacerbate the impact of psychiatric comorbidities on both children and society. Thus, it
is important to increase awareness of psychiatric comorbidities associated with epilepsy
in children to reduce the impact of these psychiatric comorbidities.

2.2 Epilepsy Worry
2.2.1

Worry

Worry is a common response to stressful events, representing an attempt to problemsolve an issue with uncertain future outcomes that contains the possibility of one or
more negative outcomes (16). However, worrisome thoughts are often unproductive or
counterproductive and can prolong or magnify negative affect (16,17). Brosschot and
colleagues (16) refer to worry as a cognitive representation of stressors that triggers the
physiological stress response, including enhanced activity across numerous physiological
parameters. These authors proposed the “perseverative cognition hypothesis” where
stressful events affect somatic health through the prolonged activation of stress-related
physiological activity, facilitated by worrying, that can ultimately result in somatic health
problems. The mediating role of worry in the effect of stress on somatic health has been
supported by other studies (18,19). Additionally, worry has been found to mediate the
effect of stress on cognition (18).

2.2.2

Worry and Anxiety

Worry is often viewed as the same construct as anxiety, and the two terms are often
used interchangeably. Worry is also the defining feature of anxiety disorders. For
example, generalized anxiety disorder (GAD) is an anxiety disorder that includes
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“persistent and excessive anxiety and worry about various domains, including work and
school performance, that the individual finds difficult to control” (20). There are,
however, subtle differences between the two constructs. Worry appears to be primarily
cognitive in nature (21,22). On the other hand, anxiety is generally conceptualized as a
global construct that includes affective, cognitive, and physiological elements (23),
although there have been attempts to differentiate worry and anxiety by ascribing
somatic responses to anxiety and cognitive processes to worry (22,24). Zebb and Beck
(22) have noted that most measures developed for anxiety include both cognitive and
somatic items, which unfortunately complicates the effort to establish a distinction
between worry and anxiety.

2.2.3

Epilepsy Worry

Seizures in epilepsy may occur anytime without warning signs. People with epilepsy may
also suffer from seizure-related injuries that are not easily preventable (25), with the
risk of injury being significantly higher compared to their siblings without epilepsy (26).
The unpredictability of seizures and the potential for physical injury related to the
occurrence of seizures during everyday activities may provoke a state of worry specific
to future seizures and their consequences in people with epilepsy. Disease-specific
mental health, specifically distress, has been previously investigated. One notable
example is diabetes-distress. Diabetes distress refers to an emotional response
(including worries, concerns, and fears) to the diabetes condition which is chronic in
nature with demanding management (27). It has been established to be distinct from
depression in people with diabetes (27). Disease-specific distress has also been
examined in inflammatory bowel disease, where it was found to be distinct from
anxiety, depression and stress (28), as well as in asthma, where an instrument has been
developed to assess the specific distress (29).
The concept of epilepsy-specific worry has been mentioned in the literature, although
not explored in detail. Worry is a common theme in qualitative studies of people with
epilepsy. In a qualitative study of children and adolescents with intractable epilepsy,
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worry regarding the unpredictability of seizures and loss of control emerged as one of
the key findings regarding the impact of epilepsy on quality of life. These children and
adolescents experienced “periods of intense emotional distress that they attributed
largely to the unpredictability of their seizures and loss of control over their bodies”
(30). Worry tends to be strongly associated with children’s attitude toward their illness
(31). When levels of worry are high, the excessive worrying may affect children’s
emotional well-being as well as influence their psychosocial adjustment to their illness.
Self-efficacy in managing seizures in children with epilepsy may also be compromised
when they worry a lot about their illness (32).
There has not been a uniform term to refer to the concept of epilepsy-specific worry. In
a review article, Beyenburg and colleagues (33) attempted to distinguish types of
epilepsy-related anxiety symptoms and comorbid anxiety that is unrelated to epilepsy.
One of the types of epilepsy-related anxiety symptoms proposed was interictal
anticipatory anxiety (IAA), which refers to “a combination of psychological worries
about the disorder and its complications” (33). If left unaddressed, it is possible for IAA
to lead to the development of a number of mental disorders, or initiate a vicious cycle of
increased levels of stress leading to increased seizure frequency and then increased IAA
(34). The concept of epilepsy-specific worry has also been referred to as seizure worry
and incorporated into an instrument for evaluating the quality of life in people with
epilepsy (35).
As discussed previously, worry is a construct distinct from anxiety, although the
distinction has yet to be fully clarified in the context of epilepsy. Also, epilepsy is a
disease that is characterized by not only seizures but also by its neurobiological,
cognitive, psychological, and social consequences (8). As such, both the terms IAA and
seizure worry do not seem to adequately capture the full scope of the concept of
epilepsy-specific worry. Thus, for the purpose of this thesis, the term epilepsy worry is
proposed to refer to an apprehensive expectation of future seizures and the
consequences of epilepsy.
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It is increasingly recognized that people with epilepsy have a higher risk of psychiatric
comorbidities, including anxiety and depression (36). When examining the mental
health care needs of people with epilepsy, epilepsy worry may be attributed to anxiety
or related conditions or be considered as part of the normal adaptation process to
epilepsy. Worrying thoughts have been found to be the most prevalent symptoms of
anxiety among people with epilepsy, which could complicate the attempt to separate
the two (37). However, there could be value in distinguishing those who are
experiencing epilepsy worry from those experiencing anxiety or depression, as they may
require different interventions to help them cope with their condition. For example,
McNelis and colleagues (38) suggested that providing information to children with
epilepsy that is tailored to their specific needs could help reduce the fears and worries
that the children are experiencing due to incomplete or incorrect information, and may
improve their attitude toward both their condition and themselves.

2.2.4

Epilepsy Worry, Adolescence, and Stigma

Adolescence is a critical period of development marked by profound physical,
psychological, and social transformations. It is also an especially vulnerable period—
about three quarters of mental disorders have their onset by 24 years of age (39).
During this stage of life, adolescents are faced with adjustment tasks such as identity
formation, increased life responsibilities, and gaining independence. For adolescents
with epilepsy, they must manage the increased stress from having to adjust to
additional challenges and limitations from their condition that could affect their
development and functioning. Examples of these additional challenges include difficulty
attaining independence, affected academic performance, and restrictions on driving and
leisure activities (40). Concerns expressed by adolescents living with epilepsy were often
related to establishing independence, future choices, and decision making (41).
A main challenge that adolescents with epilepsy often face is the stigma associated with
epilepsy, standing as one of the barriers to achieve a satisfying life. It has been
established that stigma operates on three different levels: internalized, interpersonal,
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and institutional stigma (42). In past literature, internalized stigma has also been
referred to as felt stigma, perceived stigma, or perceptions of stigma, all of which refer
to the stigma felt within the person reflecting their feelings, thoughts, beliefs and fears
about being different. All three levels of stigma could occur in the lives of people with
epilepsy, and its background and impact within the epilepsy context has been discussed
in detail in prior literature (43). For adolescents with epilepsy, stigma is prevalent in
their social environment and is especially impactful in this stage of life. A large survey of
adolescents in the United States revealed that these adolescents are often unfamiliar
with epilepsy and hold misconceptions about the illness, and the findings suggest that
these negative peer attitudes could create a difficult social environment that
contributes to internalized stigma among adolescents with epilepsy (44). Similar to
others of similar age, adolescents with epilepsy are likely to be sensitive to peer norms
and feelings of being different or singled out. They may limit the disclosure of their
condition in order to feel less different or less interpersonal stigma around their peers,
and this fear can consequently result in internalized stigma.
There have been improvements in public attitudes toward epilepsy over the recent
years (45), but stigma continues to adversely impact the lives of people with epilepsy.
Traditional ideas on epilepsy continue to contribute to public misperceptions and
negative attitudes (43,45), subsequently leading to people with epilepsy continuing to
experience discrimination or fear of being different due to their condition. Internalized
stigma has been found to be associated with poorer QoL in people with epilepsy (46).
For children and adolescents with epilepsy, internalized stigma has been found to be
associated with lower self-esteem, poorer self-concept, and increased depression and
anxiety (47–49). Internalized stigma has also been found to be associated with epilepsy
worry. In a study that sought to identify factors most strongly associated with
internalized stigma in children and adolescents with epilepsy, greater child fear and
worry about epilepsy were associated with higher levels of internalized stigma (50).
Based on their findings, the authors suggested that identifying children who are fearful
and worried about their epilepsy could help target those who are at risk of internalized
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stigma, and that interventions which address these fears and worries could help reduce
internalized stigma. For those with childhood-onset epilepsy, although the long-term
outcome is generally favourable and many will have outgrown their seizures by the time
they reach adolescence, they may continue to experience epilepsy worry due to the
unpredictability of seizures and the possibility of relapse even after long remission time.
As such, it could be beneficial to examine the levels of epilepsy worry in people with
childhood-onset epilepsy, as they may continue to experience internalized stigma after
seizure remission, which would impact development and functioning.

2.2.5

Epilepsy Worry in Published Instruments

The concept of epilepsy worry has been incorporated into several instruments for use in
people with epilepsy. The Epilepsy Surgery Inventory (ESI-55) is designed to measure
QoL in candidates for epilepsy surgery and includes an item regarding epilepsy worry as
a part of its “health perception” scale (51). The Quality of Life in Epilepsy (QOLIE)
inventory expanded upon the ESI-55 to make the instrument applicable to people with
epilepsy who are not candidates for surgery, and developed a more extensive epilepsy
worry subscale in both its original 89-item version and in its more commonly used 31item version (35,52). The QOLIE-31 includes a “seizure worry” subscale that examines
how worried an individual is regarding seizures and related events, such as injuries and
social embarrassments. In the process of adapting the QOLIE inventory for adolescents,
the seizure worry items from the QOLIE-89 did not meet the minimal statistical
standards and were excluded from the subscales and the total score; however, several
of the epilepsy worry items were retained as optional items in the final version, QOLIEAD-48, due to the potential importance for evaluating individual cases (53). The concept
of epilepsy worry was also included in the Health Related Quality of Life Measure for
Children with Epilepsy (CHEQOL-25) instrument, where its “worries and concerns”
subscale evaluates children’s and youths’ perceptions on epilepsy-related restrictions,
risks and injuries, and concerns about their parents’ worries (54). Lastly, the Child
Report of Psychosocial Care Scale was developed to assess the psychosocial care needs
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of children with seizures in the clinical setting, and includes a “concerns and fears”
section that examines how often the children were concerned or worried about their
seizures and related events (55).
Instruments that include the epilepsy worry concept have been developed, with sound
psychometric properties established, and incorporated into practice. However, the
operationalization of epilepsy worry is inconsistent in the subscales concerning epilepsy
worry across these instruments. To date, a separate instrument has not been developed
to assess epilepsy worry specifically and include all possible aspects of epilepsy worry;
an optimal choice for assessing epilepsy worry has yet to be established.

2.3 Parents’ Worry
2.3.1

Impact of Children’s Epilepsy on Families

Childhood-onset epilepsy not only affects the child but also affects the child’s family.
Families of children with epilepsy often face more difficulties compared to other
families, including in quality of the parent-child relationship, family stress and
functioning, and family cohesion (56). For parents, caring for children with epilepsy is a
challenging and stressful responsibility and the uncertainty related to when the next
seizure may occur, as well as to the child’s current and future state of health, adds
additional stress and burden. Due to the caregiving burden, parents of children with
epilepsy often experience impaired QoL (57,58), although it has been found that the
long-term health-related quality of life (HRQoL) of mothers was comparable to women
in the general population many years after their child’s epilepsy diagnosis (59). Parents
of children with epilepsy also frequently experience symptoms of depression (60,61)
and anxiety (61) above the threshold where individuals are considered to be at-risk for a
clinical diagnosis, and their scores are generally higher than parents of healthy children
(58,60,61). Mothers are at an especially increased risk of depression, anxiety, and stress
compared to fathers in response to the burden of caring for children with epilepsy, as
they are often the primary caregivers (62).
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2.3.2

Parents’ Worry and Children’s Outcomes

When factors such as family functioning and parents’ emotional well-being are impacted
by the diagnosis of epilepsy and the burden of caring for children with epilepsy, these
factors can in turn influence the child. For example, the same review that reported
symptoms of anxiety in parents of children with epilepsy also found that increased
parents’ anxiety is associated with reduced child HRQoL and worse adaptive behaviour
(61). Parents’ perception of the health of their child with epilepsy can also be influenced
by the impact that epilepsy has on parents. Due to the social stigma, unpredictability of
seizures, and burden of managing the disease, parents of children with epilepsy may
express heightened worry and concerns about the child, possibly more than the child’s
own concerns. The discrepancies based on perspectives can be seen by comparing
parent proxy-reports and child self-reports. For example, when evaluating a child’s
HRQoL, parents of children with epilepsy often report their child having lower levels of
HRQoL and higher levels of behavioral problems compared to sibling controls, while the
children report levels comparable to sibling controls (63,64). Most of the discrepancy
between parent and child report could be accounted by the emotional impact of
children’s epilepsy on parents (64), although it has been found that maternal depression
does not contribute to an under-estimation of the child’s health (65).
Parents of children with epilepsy play a key role in determining how their child will
adapt to their condition. When parents worry excessively and hold a pessimistic attitude
toward their child’s health and QoL, they may adopt an over-protective or overcontrolling parenting style, placing restrictions on their child’s activities and limiting
their child’s autonomy (66). This parenting style could in turn influence their child’s
psychosocial well-being (66,67). Children with epilepsy have also been found to be
significantly more dependent on their mothers than children in the general population
or those with diabetes (68), and this dependency could partly be accounted for by
parental overprotection (69). When children experience overprotective parenting and
are dependent on their caregivers, their self-management capability is likely to be
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compromised (69). An over-protective parenting style, along with its effect on the
child’s psychosocial well-being and development, influences children’s adjustment to
their epilepsy and development of the skills necessary as they step into young
adulthood.

2.4 Limitations of Past Studies
Past studies that focused on identifying epilepsy worry are often qualitative in nature,
describing how people with epilepsy feel about their condition. In most of the
quantitative studies, epilepsy worry was included as part of a measure, most often
those assessing QoL such as the QOLIE and CHEQOL-25, and was assessed as a predictor
for a different outcome of interest. There has been a lack of studies measuring epilepsy
worry as an outcome. As well, the extent to which people with epilepsy experience
epilepsy worry and the relationships between epilepsy worry and possible risk factors
have not been systematically explored. This could possibly be due to the inconsistencies
regarding what should be covered by this concept, and the absence of an instrument
developed specifically for epilepsy worry that includes all possible aspects. In addition,
research focus has been placed more heavily on individuals with severe or poorlycontrolled epilepsy. Those with well-controlled or less severe epilepsy, or those who
have been in remission or achieved resolution, were often excluded from studies. Due
to the unpredictability of seizures and the possibility of relapse after remission, these
individuals may continue to experience epilepsy worry and its associated impacts and
should be included in studies on epilepsy worry to provide more insight on its risk
factors and extent of impact.
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Chapter 3

3

Study Objectives and Conceptual Framework

This chapter presents the objectives of this thesis and the conceptual framework that
was used to guide the data analysis.

3.1 Study Objectives
The overall goal of this thesis was to describe epilepsy worry in AYAs with childhoodonset epilepsy and the worries experienced by their parents. The specific objectives
were as follows:
1. To describe the extent to which AYAs with childhood-onset epilepsy experience
epilepsy worry, and to explore its associations with epilepsy severity and other
clinical, demographic, and family characteristics.
2. To explore the extent to which epilepsy worry correlates with anxiety and
depression in AYAs with childhood-onset epilepsy.
3. To explore the extent to which parents of AYAs with childhood-onset epilepsy
experience worry regarding their child's health, and whether it mediates the
effect of epilepsy severity on AYAs’ epilepsy worry.

3.2 Conceptual Framework
The stress process model was used to guide the data analysis in this thesis (70). The
stress process model is a conceptual paradigm that has provided theoretical foundations
for many sociological studies on stress and mental health since it was introduced. The
focus of the model is to understand how stress arises to affect mental health outcomes,
and the interrelationship among the factors that contribute to this process (70–72). The
stress process model acknowledges the temporal nature of the interrelationships
among many of these factors, and helps to provide a better understanding of the
relationship between the exposure and the outcome of interest. The perspectives of the
stress process arose from a study conducted by Pearlin and colleagues (70) analyzing
the effects of involuntary job loss on depression. The study found that the event of
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involuntary job loss led to secondary stressors including financial and marital strain,
which largely accounted for the effect of involuntary job loss on depression. The same
study also found that personal and social resources, such as social support, mastery, and
self-esteem, played a role in mediating and moderating the effects of stressors on
depression. Following the introduction of this stress process perspective, the model has
been successfully applied in many epidemiologic studies on mental health outcomes,
including depression in people with physical disability and matched controls (73),
depression in the general population (74), depression and physical health in family
caregivers of dementia patients (75), depression and life satisfaction in spousal
caregivers of hospice patients with dementia or lung cancer (76), distress in caregivers
of dementia patients (77), and studies on HRQoL, emotional well-being, and cognitive
functioning in children with epilepsy (78–80). The stress process model has not been
previously applied in studies on epilepsy worry, but it could offer a framework for
research on epilepsy worry, given its track record of successful applications to studying
the effects of stress on mental health outcomes.
The stress process model consists of three core components: stressors, stress
mediators, and stress outcomes. Stressors are conditions that may impact mental health
and can give rise to secondary stressors. Stressors typically arise out of two
circumstances, the occurrence of discrete life events and the presence of chronic
problems, and these two sources of stress work synergistically to produce stress
outcomes (70–72). The production of stress outcomes by these stressors can be direct,
or they can act indirectly through stress mediators. Lastly, the stress process model
acknowledges that the underlying characteristics of each individual, such as age, sex,
socioeconomic status, and other background and contextual factors, could lead to
variations in the stress outcome (70–72).
Figure 3.1 presents the theoretical framework used to guide this thesis. For the purpose
of this thesis, the initial stressors to produce a stress outcome were the diagnosis of
epilepsy and living with epilepsy. The severity of the AYAs’ epilepsy was used as a proxy
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to represent the amount of stress experienced from these sources. Epilepsy severity
then acts directly or indirectly through parents’ worry to produce the outcome of
interest, epilepsy worry. The background factors that could possibly affect the stress
outcome and were assessed in this thesis include both clinical characteristics (recency of
last seizure, current use of AEDs, seizure type, behavioural comorbidities, cognitive
comorbidities), and demographic characteristics (AYA age, AYA sex, parents’ age,
parents’ depressive symptoms, parents’ marital status, family income). Psychosocial
aspects of the family environment have also been previously found to be associated
with behavioural and psychiatric problems (56,81), psychosocial adaptation (82), and
overall HRQoL (83) in children with epilepsy, and could possibly influence a child’s
psychological adjustment to epilepsy more than clinical factors (84). As such, it would be
beneficial to also include factors on the psychosocial aspects of the family environment
in the model and explore whether these factors have a potential effect on the AYAs’
epilepsy worry. Lastly, anxiety and depression were included as constructs overlapping
with the stress outcome epilepsy worry. The overlap between worry and anxiety was
discussed in the previous chapter. Depression has been conceptualized as an emotion
that is distinct from anxiety but has common characteristics (85). Depression has been
shown to be associated with both worry and anxiety in past studies and is significantly
correlated with anxiety in people with epilepsy, thus it is also included in the model for
assessing the extent of correlation among these three constructs (21,37,86,87).
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Figure 3.1: Conceptual framework for this thesis.
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Chapter 4

4

Methods

This chapter describes the methodology employed in this thesis. Section 4.1 presents
details on the source of the data, followed by descriptions of measurement tools used in
this thesis in section 4.2. The chapter closes with a description of the statistical analysis
methods in section 4.3.

4.1 Data Source and Sample
The data used in this thesis arose from HERQULES, a national multicenter prospective
cohort study which followed children in Canada with newly diagnosed epilepsy for
approximately 10 years after diagnosis. There were two phases of HERQULES: The initial
phase sought to assess the course of HRQoL in children with epilepsy over the first two
years after diagnosis of epilepsy, and to assess the risk and protective factors for HRQoL.
The second phase followed up with the initial cohort at approximately 8 and 10 years
after diagnosis to examine the long-term course of HRQoL and associated child and
family characteristics. Each phase of HERQULES was funded by a Canadian Institutes of
Health Research Operating Grant (MOP-63411 and MOP-115015).
Beginning in 2004, all practicing paediatric neurologists treating children with epilepsy
across Canada were invited to participate in the study. A total of 72 neurologists were
eligible, and 53 (74%) agreed to participate. These neurologists were asked to inform
the parents or caregivers of all consecutive patients who met the study inclusion criteria
about the study over a 36-month period. Patients were considered to be eligible for the
study if:
1. they were seen for the first time by a participating paediatric neurologist for
epilepsy;
2. they were diagnosed between 4 and 12 years of age; and
3. their parent/caregiver who would be participating in the study had been the
child’s primary caregiver for at least the past six months.
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Patients were ineligible for the study if they were diagnosed with other degenerative
neurological disorders or major comorbid disorders likely to affect quality of life, or if
their parent/caregiver (hereafter referred to as parents) did not have sufficient English
language proficiency to complete the study questionnaires. It should be noted that the
definition of a new case of epilepsy for inclusion in HERQULES during the recruitment
phase was two or more unprovoked seizures >24h apart, typically used by clinicians and
researchers at that time. The definition of epilepsy was updated by ILAE in 2014 to
include special circumstances that do not meet the old definition (1).
Ethics approval for the first phase of the study was obtained from the research ethic
boards governing each of the 17 participating paediatric neurologists’ centers across
Canada. For the second phase, ethics approval was only required from the Western
University Health Science Research Ethics Board given that the research team had
already established relationships with the participants to re-contact them directly
(Western University Health Sciences Research Ethics Board file #10069E and #102819).
The first phase of HERQULES followed the participants for approximately two years after
diagnosis and collected data at four time points: baseline, 6 months, 1 year, and 2 years
post-diagnosis. Parents were asked to complete mailed questionnaires at these four
times. Parents were also asked to give consent for their paediatric neurologist to
provide their child’s clinical information to the study team. For each child whose parent
consented, neurologists were asked to complete an assessment form to describe the
clinical features of the child’s epilepsy at the same four data collection times (Appendix
A). A total of 455 eligible families were identified, 373 (82%) of whom were successfully
recruited and 282 (76%) of whom were retained at the 2-year follow-up.
In the second phase of HERQULES, the families that completed the first phase were recontacted and asked to participate in two additional assessments at approximately 8
and 10 years post-diagnosis. Self-report by AYAs was introduced in these two additional
assessments, and AYAs were eligible to provide self-report if they were aged 11 years or
older. A total of 220 AYAs were eligible to provide self-report at the beginning of the
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second phase of HERQULES. Informed consent was again sought to contact the
physician currently providing epilepsy care, if applicable, to obtain the AYAs’ clinical
information. Consent was sought from AYAs who were 18 years or older, from both the
parents and AYAs 16-18 years of age, and from parents if the AYAs were younger than
16 years.
Both phases of HERQULES followed the Tailored Design Method to encourage
participation and retention in the study. The technique has been shown to maximize
response rates and data quality in survey research studies, and includes the use of
systematic follow-up and reminders, annual contact by mail, and tokens of appreciation
for participation (88). The Tailored Design Method was applied in the communications
with the AYAs, the participating parents, and the paediatric neurologists.

4.2 Measures
Data from the baseline, 2-year, 8-year, and 10-year follow-up of HERQULES were used.
Variables that were examined in this thesis are presented below in the order of
exposure, outcome, potential mediator, and covariates.

4.2.1

Exposure: Epilepsy Severity

Neurologists rated the severity of the AYAs’ epilepsy using the Global Assessment of
Severity of Epilepsy (GASE) scale, a single-item, 7-point Likert scale developed for
HERQULES (89). The GASE scale ranged from 1 (extremely severe) to 7 (not at all
severe), with higher scores indicating less severe epilepsy. The scale allows clinicians to
report on the overall severity of epilepsy, taking into consideration the multidimensional
nature of epilepsy. The GASE scale has demonstrated adequate validity, reliability, and
responsiveness (89,90). As the clinical management of epilepsy is often dynamic during
the initial period following diagnosis, epilepsy severity was measured at the 2-year
follow-up when the situation has more likely stabilized to allow the neurologists to
make a more accurate categorization of the clinical characteristics of the AYAs’ epilepsy
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and attempt to determine whether the AYAs’ seizures could be controlled by
combinations of AEDs.

4.2.2

Outcome: Epilepsy Worry

Information regarding epilepsy worry was obtained from the AYAs at the 10-year followup. Epilepsy worry was measured using the QOLIE inventory—an instrument that
measures HRQoL for people with epilepsy and contains a section for epilepsy worry.
Two versions of QOLIE were used: QOLIE-31 for young adults (age 18+) and QOLIE-AD48 for adolescents (age 11-17) (35,53). In the QOLIE-31, epilepsy worry is measured with
a “seizure worry” subscale consisting of five items, measuring the frequency and
intensity of seizure-related worry (Table 4.1). Epilepsy worry is not a subscale in QOLIEAD-48. Instead, three items, two of which are analogous to the items in QOLIE-31, are
included as optional items (Table 4.2). AYAs given the QOLIE-AD-48 were able to choose
not to respond to these three items. The three items measure the frequency of seizurerelated fear or worry over the past four weeks using a 5-point scale, with higher scores
indicating lower frequency (1: Very often; 5: Never).
Table 4.1: Epilepsy worry items in QOLIE-31 (designed for young adults aged 18+).
* Have you worried about having another seizure?
(1 = All of the time … 6 = None of the time)
How fearful are you of having a seizure during the next month?
(1 = Very fearful … 4 = Not fearful at all)
* Do you worry about hurting yourself during a seizure?
(1 = Worry a lot 2 = Occasionally worry 3 = Don’t worry at all)
How worried are you about embarrassment or other social problems resulting from having a
seizure during the next month?
(1 = Very worried … 4 = Not worried at all)
For each of these PROBLEMS, circle one number for how much they bother you
1. Seizures
(1 = Not at all bothersome … 5 = Extremely bothersome)
*common items between QOLIE-31 and QOLIE-AD-48 selected to combine the two age groups.
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Table 4.2: Epilepsy worry items in QOLIE-AD-48 (designed for adolescents aged 11-17).
In the past 4 weeks, how often did you:
* Worry about having another seizure?
(1 = Very often … 5 = Never)
Fear dying because of seizures?
(1 = Very often … 5 = Never)
* Worry about hurting yourself during a seizure?
(1 = Very often … 5 = Never)
*common items between QOLIE-31 and QOLIE-AD-48 selected to combine the two age groups.

Both versions of QOLIE have been assessed for their psychometric properties. The
QOLIE-31 has been shown to have good discriminant validity in terms of the differences
in seizure frequency and severity categories (35). QOLIE-31 has also demonstrated
acceptable internal consistency (Cronbach's a = 0.77-0.85) and test-retest reliability
(Pearson’s r = 0.64-0.85), with the seizure worry subscale scores of Cronbach's a = 0.79
and Pearson’s r = 0.84 (35). The QOLIE-AD-48 has also demonstrated good construct
validity, internal consistency, and test-retest reliability (53); however, the epilepsy worry
items used for the purposes of this thesis were optional items and were not included as
a part of any subscale or the summary score for the instrument, and therefore were not
included in these assessments. Although these items in QOLIE-AD-48 were not validated
and cover fewer aspects of epilepsy worry compared to the seizure worry subscale in
QOLIE-31, they still capture the main concerns of epilepsy worry, specifically worry
about having another seizure and worry about injuries from seizure, which this thesis is
interested in. These items are also sensitive to change in levels of epilepsy worry by
employing the Likert scale, instead of a yes/no question. These items from the QOLIEAD-48 have demonstrated good internal consistency in the HERQULES sample of AYAs,
with Cronbach's a = 0.86.
In order to analyze the whole sample together and not lose statistical power, the two
items that were common between QOLIE-31 and QOLIE-AD-48 (worry about having
another seizure and worry about injuries from seizure) were selected to be used.
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Following the scoring scheme of QOLIE-31 (91), the two individual items were first
converted to a score of 0-100, then added together and divided by 2 to generate an
epilepsy worry score of 0-100. For this score, higher values indicate less epilepsy worry,
due to the direction of the response options. Thus, the scores were subtracted from 100
to generate an epilepsy worry score of 0-100 where higher values indicate higher levels
of epilepsy worry. The scores were dichotomized into whether epilepsy worry was
absent or present (0 vs 1-100), and the frequency from the two sub-groups of younger
and older participants was combined. For evaluating the level of epilepsy worry when it
is present, Z-scores for the two sub-groups were calculated among those who
experienced epilepsy worry, and the resulting Z-scores from the two sub-groups were
combined.

4.2.3

Potential Mediator: Parents’ Worry

Information regarding parents’ worry was obtained from the Child Health Questionnaire
– Parent Form (CHQ-PF50), a parent-report measure evaluating HRQoL for children and
adolescents aged 5 to 18 years (92). Parents’ worry was obtained at the 8-year followup to allow for a reasonable temporal sequence between exposure (epilepsy severity),
mediator (parents’ worry), and outcome (epilepsy worry). The CHQ contains 13 health
concepts: nine are HRQoL concepts focusing on the child, while the remaining four
concepts measure the impact on the family. The questions used to evaluate parents’
worry in this thesis were derived from the “parental impact – emotional” concept from
the CHQ. This concept examines the levels of worry the parent experienced over the
past 4 weeks regarding three aspects of their child’s health: physical health, emotional
well-being or behaviour, and attention or learning abilities (Table 4.3). Each of the three
aspects is scored on a 5-point scale, from “none at all” to “a lot”. The CHQ provides
scoring for each individual concept in the measure (92). The “parent impact-emotional”
subscale scoring ranges from 0-100, with higher scores indicating lower levels of
parents’ worry. The subscale has acceptable internal consistency within the HERQULES
sample of AYAs, with Cronbach's a = 0.80.
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Table 4.3: “Parental impact – emotional” concept from CHQ-PF50.
During the past 4 weeks, how much emotional worry or concern did each of the following
cause you?
a. Your son’s/daughter’s physical health
(None at all – A little bit – Some – Quite a bit – A lot)
b. Your son’s/daughter’s emotional well-being or behaviour
(None at all – A little bit – Some – Quite a bit – A lot)
c. Your son’s/daughter’s attention or learning abilities
(None at all – A little bit – Some – Quite a bit – A lot)

4.2.4

Covariates: Adolescents and Young Adults

Anxiety
Assessments of anxiety were obtained from AYAs’ self-report at the 10-year follow-up.
Anxiety was measured using the Spielberger State-Trait Anxiety Inventory short-form
(STAI: Y-6) (93) (Appendix B). The 6-item inventory measures a person’s current level of
anxiety with a 4-point scale and has a total score range of 20 to 80 with higher scores
indicating higher anxiety. The inventory has been shown to have good validity and
reliability (93). The inventory has acceptable internal consistency within the HERQULES
sample of AYAs, with Cronbach's a = 0.87.
Depression
Assessments of depression were obtained from AYAs’ self-report at the 10-year followup. Depression was measured using the Centre for Epidemiological Studies Depression
Scale (CES-D), an instrument that has been validated and is frequently used in general
population surveys (94) (Appendix B). The CES-D is a 20-item self-reported scale that
measures depressive symptoms over the past 4 weeks using a 4-point scale. The total
score for CES-D ranges from 0 to 60 with higher scores indicating greater depressive
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symptoms. A score of 16 or greater is indicative of clinically relevant depression (94).
The CES-D has been found to have good psychometric properties in the general
population (94). The instrument has acceptable internal consistency within the
HERQULES sample of AYAs, with Cronbach's a = 0.92.
AYAs’ age
AYAs’ age at the 10-year follow-up was determined by computing the time between the
completion date of the AYAs’ 10-year follow-up questionnaire and the AYAs’ date of
birth.
AYAs’ sex
AYAs’ sex (male or female) was reported by their parents at baseline.
Recency of last seizure
At the 10-year follow-up, AYAs were asked to indicate when their last seizure was, or to
provide a best guess if they were not sure. The response options were: less than 6
months ago; 6 months ago to less than 1 year ago; 1 year ago to less than 2 years ago; 2
years ago to less than 5 years ago; 5 years to less than 10 years ago; 10 years ago or
more; I don’t remember. For AYAs who could not recall or did not report on the recency
of their last seizure, their parents’ reported value on the same question was imputed.
Due to the unequal time intervals between the individual response options, this variable
was dichotomized into whether or not the AYA had achieved 5-year seizure freedom at
the 10-year follow-up.
Current use of AEDs
At the 10-year follow-up, AYAs were asked “Are you currently taking any medication(s)
to treat epilepsy or seizures?”. The response options were “yes” and “no”. For those
who reported that they were not currently taking medications for their epilepsy or
seizures, they were asked “When was the last time you took medication for epilepsy or
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seizures?” The response options were: less than 6 months ago; 6 months to less than 1
year ago; 1 year to less than 2 years ago; more than 2 years ago; I have never taken
medication(s) for epilepsy or seizures; I don’t remember.
Seizure type
Neurologists reported on AYAs’ epilepsy syndrome as well as seizure type based on the
ILAE’s classifications (primary generalized, absence, simple/complex partial, benign
epilepsy of childhood with rolandic spikes (BECRS), secondarily generalized, BECRS +
secondarily generalized, or undetermined) (95,96). These data were then used to create
a more general category of the AYAs’ seizure type (generalized, partial, or
undetermined). Data regarding seizure type were taken from the same 2-year follow-up
time as the exposure of interest (epilepsy severity).
Behavioural comorbidities
At the 2-year follow-up, neurologists were asked “Does the patient have behavioural
problems?” and the response options were “no (normal)” and “yes”. If the response was
“yes”, the neurologists were also asked to report on the severity (mild, moderate, or
severe) of the behavioural problems and the diagnosis (if any). The data collected were
combined into a dichotomous variable of “yes” and “no”.
Cognitive comorbidities
At the 2-year follow-up, neurologists were asked “Does the patient have cognitive
problems?” and the response options were “no (normal)” and “yes”. If the response was
“yes”, the neurologists were also asked to report on the severity (borderline, mild,
moderate, or severe) of the cognitive problems and the diagnosis (if any). The data
collected were combined into a dichotomous variable of “yes” and “no”.
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4.2.5

Covariates: Parents and Families

Parents’ age
Parents’ age at the 10-year follow-up was determined by computing the time between
the date of completion of the questionnaire and the parents’ date of birth.
Parents’ depressive symptoms
Parents’ depressive symptoms were assessed at the 10-year follow-up, using the same
CES-D scale as used in the AYA self-reports as described earlier (94). The instrument has
a good internal consistency within the sample of AYAs’ parents, with Cronbach's a =
0.91.
Parents’ marital status
Parents reported on their marital status (married, widowed, divorced, separated,
remarried, never married) at the 10-year follow-up. The categories were collapsed to
create a binary variable indicating whether parents were currently married (married,
remarried) or not (widowed, divorced, separated, never married).
Family income
Parents were asked to report their yearly household income before taxes at the 10-year
follow-up. The response options ranged from less than $20,000 to greater than
$150,000. These categories were collapsed into fewer categories (less than $50,000,
$50,000 to $99,999, $100,000 - $149,000, greater than $150,000) for analysis to account
for low cell counts in some of the response categories.
Family resources
Level of family resources at the 10-year follow-up was assessed using the Family
Inventory of Resources for Management (FIRM), a self-report instrument using a 4-point
Likert scale for assessing the extent to which resources are available for families to
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adapt to stressful life events (97). The FIRM contains four subscales, two of which
(Family Strength: Mastery and Health (20 items), Extended Family Support (4 items))
have been found to be associated with adaptation to childhood epilepsy and were
selected for use in HERQULES (98) (Appendix C). The scoring ranges from 0 to 72, with
higher scores indicating more resources. The instrument has been found to have
acceptable validity and reliability (Family Strength: Mastery and Health subscale:
Cronbach's a = 0.85, Extended Family Support subscale: Cronbach's a = 0.62) (97). The
instrument has acceptable internal consistency in our sample, with Cronbach's a = 0.93
for the Family Strength: Mastery and Health subscale and Cronbach's a = 0.83 for the
Extended Family Support subscale.
Family demands
Family demands at the 10-year follow-up were assessed using the Family Inventory of
Life Events & Changes (FILE), a 71-item self-report measure of family stress in the
previous year across 9 domains (97) (Appendix C). The FILE accounts for both normative
and non-normative life events experienced by the family, and scores can be obtained for
each domain as well as a total “pile up” scale. The FILE score ranges from 0 to 71, with
higher scores indicating more family stress in the previous year. The FILE has
demonstrated acceptable discriminant validity, internal consistency (Cronbach's a =
0.72), and test-retest reliability (Pearson’s r = 0.80) (97). The instrument has acceptable
internal consistency in our sample (Cronbach's a = 0.81).
Family adaptation
Family adaptation at the 10-year follow-up was measured using the Family Adaptability,
Partnership, Growth, Affection and Resolve (APGAR) (99) (Appendix C). The instrument
has five items scored using a 5-point Likert scale, and the total score ranges from 0 to 20
where higher scores indicate higher satisfaction with family functioning. The APGAR has
been found to be both valid and reliable (99–101). The instrument has acceptable
internal consistency in our sample, with Cronbach's a = 0.90.
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4.3 Statistical Analysis
All analyses were conducted using Stata/MP 13.0 for Mac (StataCorp, College Station,
TX, USA).

4.3.1

Sample Characteristics

Summary statistics were used to describe the clinical, demographic, and family
characteristics of the sample. Means and standard deviations were reported for
continuous variables, and frequencies and proportions were reported for categorical
variables.

4.3.2

Analysis for Objective #1

Objective #1: To describe the extent to which AYAs with childhood-onset epilepsy
experience epilepsy worry, and to explore its associations with epilepsy severity and
other clinical, demographic, and family characteristics.
The presence or absence of epilepsy worry was summarized using frequencies and
proportions. The epilepsy worry scores among those who experienced epilepsy worry
were standardized and summarized using a histogram of the score distribution. Bivariate
analyses were conducted to assess the associations of the presence and level of epilepsy
worry with epilepsy severity, other clinical epilepsy characteristics, demographic, and
family characteristics, without controlling for other factors. The factors assessed
included: AYA age, AYA sex, recency of last seizure, current use of AEDs, seizure type,
behavioural comorbidities, cognitive comorbidities, parents’ age, parents’ depressive
symptoms, parents’ marital status, family income, family resources, family demands,
and family adaptation.
Multivariable analyses were conducted to assess the relationship between epilepsy
worry and epilepsy severity and other clinical, demographic, and family characteristics.
A preliminary analysis revealed that there was a large number of zeros in the epilepsy
worry scores, suggesting that the majority of AYAs did not experience epilepsy worry.
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Zero-inflated and hurdle models are commonly considered when the outcome of
interest include excess zeros. Zero-inflated models contain zeros arising from two
different processes: from at-risk and not-at-risk populations in public health
perspectives, while hurdle models only contain zeros arising from one at-risk population
(102). For the purposes of this thesis, all AYAs in the sample have childhood-onset
epilepsy and were at risk of experiencing epilepsy worry. As such, the hurdle model was
chosen over the zero-inflated model. A logistic regression was first performed with the
outcome being presence or absence of epilepsy worry, which represents the “hurdle” to
be crossed in the hurdle model. Odds ratios from the logistic regression were reported
for this portion of the model. After the hurdle is crossed, the level of epilepsy worry
among the AYAs who did experience epilepsy worry was modelled using the gamma
distribution due to the epilepsy worry scores being continuous and highly positively
skewed. Mean ratios were reported for this portion of the model.

4.3.3

Analysis for Objective #2

Objective #2: To explore the extent to which epilepsy worry correlates with anxiety and
depression in AYAs with childhood-onset epilepsy.
The hurdle model approach was also applied to examine the extent to which epilepsy
worry correlates with anxiety and with depression. The correlations between the
presence or absence of epilepsy worry and anxiety and between the presence or
absence of epilepsy worry and depression were evaluated using point-biserial
correlation, which is mathematically equivalent to the Pearson correlation. The
correlations between the level of epilepsy worry and anxiety and between the level of
epilepsy worry and depression among the AYAs who experienced epilepsy worry were
evaluated using Pearson correlation. The correlation between anxiety and depression
was also examined using Pearson correlation.
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4.3.4

Analysis for Objective #3

Objective #3: To explore the extent to which parents of AYAs with childhood-onset
epilepsy experience worries regarding their child's health, and whether it mediates the
effect of epilepsy severity on AYAs’ epilepsy worry.
Parents’ worry score was summarized using sample mean, standard deviation, range,
and sample distribution. Mediation was examined using the Baron and Kenny method,
which suggests the following steps for establishing mediation (103):
1. Assess the association between the exposure (epilepsy severity) and the
outcome (epilepsy worry);
2. Assess the association between the exposure (epilepsy severity) and the
potential mediator (parents’ worry); and
3. Assess the association between the potential mediator (parents’ worry) and the
outcome (epilepsy worry), adjusting for the exposure (epilepsy severity).
Baron and Kenny suggest that all three steps should be met in order to establish
mediation (103). However, several authors have argued that a significant association in
step one is not required to establish mediation, as the requirement would rule out the
possibility of a suppression effect in which the indirect effect and the direct effect have
opposite directions and may cancel out (104–106). Given this, the subsequent steps
were performed regardless of the significance of the association assessed in step one.
The mediation analyses were also performed using the binomial-gamma hurdle model.
Each association was first assessed with the outcome being the presence or absence of
epilepsy worry, and assessed again with the outcome being the level of epilepsy worry
among those who experienced epilepsy worry.

4.3.5

Attrition Analysis

To assess the potential for attrition bias, characteristics of families that completed
baseline and 10-year follow-up questionnaires were compared to those of families that
completed baseline but not 10-year follow-up questionnaires. Characteristics that were
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included in the attrition analysis were: child age, child sex, epilepsy severity, seizure
type, behavioural problems, cognitive problems, parents’ age, parents’ depressive
symptoms, parents’ worry, parents’ marital status, family income, family resources,
family demands, and family adaptation. T-tests were used to compare continuous
variables and chi-square tests/fisher’s exact tests were used to compare proportions for
categorical variables.

4.3.6

Missing Data

Complete data were available for about 70% of the sample. A comparison of AYAs who
had complete data versus those who did not have complete data was made to assess
whether the characteristics of the two groups differed significantly (Appendix D). The
proportion of missing data for each individual variable of interest is shown in Table 4.4.
Most of the missing data were in demographic variables from questionnaires that were
not returned at the 10-year follow-up, or in AYAs’ clinical characteristics due to missing
paediatric neurologist reports at the 2-year follow-up. A complete-case analysis would
exclude over 25% of participants, yielding potentially biased and inefficient results.
Multiple imputation (107) was used to address missing data in this thesis. In particular,
the multiple imputation by chained equations (MICE) method was adopted for its
flexibility to accommodate arbitrary missing patterns and use a separate conditional
distribution for each imputed variable (108). Specifically, using the MICE method, one
can use logistic regression models to impute categorical data, and linear regression
models to impute continuous data. One can also impute data using MICE through the
predictive mean matching method, which fills a missing value by matching the missing
value with the closest predictive mean (109). The advantage of predictive mean
matching is that the imputed values are guaranteed to be consistent with the observed
values, as the method samples values form the observed data. This method is less
sensitive to violations of model assumptions compared to imputation by parametric
regression (110). All variables involved in the analysis were used for the imputation to
maintain congeniality between the imputation models and the analysis models. To
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perform multiple imputation, the missing data were filled in m times with estimated
values, creating m complete data sets. Each of the imputed data sets were then
analyzed using the desired statistical method, and the estimates from each analyzed
data set were combined using Rubin’s rule (107) to produce a single set of results. To
reduce the sampling error from imputations and prevent loss of statistical power, 20
imputations were made based on the recommendations of Graham and colleagues for
10% to 30% of missing data (111).
Table 4.4: Proportion of missing data for each variable of interest.
Variable

% missing

AYA-report
AYA age

0

5-year seizure freedom

0.8

AED use

2.3

Neurologist-report
Epilepsy severity

9.2

Seizure type

13.8

Behaviour comorbidities

8.5

Cognitive comorbidities

9.2

Parent-report
AYA sex

0

Parents’ age

7.7

Parents’ worry

3.8

Parents’ depressive symptoms

7.7

Parents’ marital status

7.7

Family income

8.5

Family resources

7.7

Family demands

7.7

Family adaptation

7.7

AYA, adolescent and young adult; AED, anti-epileptic drug.
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Chapter 5

5

Results

This chapter presents the findings of this thesis. The sample characteristics are first
described in section 5.1, followed by results of attrition analysis in section 5.2. The last
three sections (sections 5.3 – 5.5) present the results for each research objective.

5.1 Sample Characteristics
At the 10-year follow-up, 176 questionnaires were sent to AYAs, and 131 returned
completed questionnaires. One AYA did not report on the outcome of interest (epilepsy
worry) and was excluded from the study. The characteristics of the 130 AYAs included in
the study are summarized in Table 5.1. The AYAs were on average 17.8 years old (SD =
2.6) and the age ranged from 12 to 23 years old. The proportions of males and females
in this sample were similar, with 47.7% male and 52.3% female. The majority (82.4%) of
the AYAs were still going to school at the 10-year follow-up. In terms of their current
epilepsy status, the majority (63.1%) of AYAs had been seizure-free for at least five
years, and about 14.0% of AYAs had experienced seizures within the last year. About
three quarters of the AYAs (73.2%) reported that they were no longer taking AEDs. The
majority (65.4%) of the AYAs were no longer receiving care for their epilepsy or seizures
at the 10-year follow-up, whereas 26.0% of the AYAs continued to receive care for their
epilepsy or seizures from either an adult neurologist, paediatric neurologist, or family
doctor/general practitioner.
Of the 130 AYAs included in the study, 119 of their paediatric neurologists provided
information about the AYAs’ clinical characteristics at the 2-year follow-up. These
characteristics are summarized in Table 5.2. For most of the AYAs, their epilepsy severity
was either “not at all severe” (60.2%) or “a little severe” (24.6%) two years after their
epilepsy diagnosis. The seizure type at the same time point was generalized for 40.2% of
AYAs and partial for 56.3% of AYAs. In terms of comorbidities, 14.3% of AYAs had
behavioural problems and 20.2% had cognitive problems at the 2-year follow-up.
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The characteristics of the parents of AYAs at the 10-year follow-up are summarized in
Table 5.3. Of the 130 AYAs included in the study, 120 of their parents returned
completed questionnaires at the 10-year follow-up. The majority (90%) of these parents
were the AYAs’ biological mothers. These parents were on average 48.8 years old (SD =
5.2) at the 10-year follow-up and the majority (82.5%) were currently married with 2.5%
being remarried. These parents scored an average of 10.1 (SD = 8.9) on the CES-D scale,
with 22.5% having clinically significant depressive symptoms. The AYAs’ family
characteristics at the 10-year follow-up are also presented in Table 5.3. About half
(50.4%) of the families had an annual household income of $100,000 or greater. On
average, the families had adequate resources (FIRM = 51.7, SD = 11.9), reported low
levels of stress (FILE = 8.4, SD = 5.9), and were functioning well (APGAR = 14.6, SD = 4.0).

5.2 Attrition Analysis
Figures 5.1 and 5.2 present the timeline for HERQULES and the number of participants
at each data collection time point. At baseline, a total of 373 families participated in the
study. AYA self-report was added for the second phase of the study at 8 and 10 years
post-diagnosis. At the 10-year follow-up, 131 AYAs returned completed questionnaires.
Table 5.4 presents the results of attrition analysis comparing the baseline characteristics
between families who participated in the 10-year follow-up and were included in the
current study (n = 130) with those who were lost to follow-up (n = 243). The two groups
were similar in terms of AYAs’ sex, age, epilepsy severity, seizure type, parents’ marital
status, and family adaptation. However, AYAs who were lost to follow-up were more
likely to have behavioural or cognitive problems at the time of epilepsy diagnosis. The
families lost to follow-up had lower household income, fewer family resources, and
more family stress in the previous year, and the parents in these families were on
average younger and experienced more depressive symptoms and more worry
regarding their child’s health at baseline.
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Figure 5.1: HERQULES participant flow diagram (parent/family).
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Figure 5.2: HERQULES participant flow diagram (AYA).

5.3 Results for Objective #1
Objective #1: To describe the extent to which AYAs with childhood-onset epilepsy
experience epilepsy worry, and to explore its associations with epilepsy severity and
other clinical, demographic, and family characteristics.
At the 10-year follow-up, 80 (61.5%) AYAs had not experienced any epilepsy worry
within the past four weeks, while 50 (38.5%) AYAs had experienced at least some
epilepsy worry. Among these 50 AYAs experiencing some epilepsy worry, 18 (36%) had
achieved 5-year seizure freedom, while 32 (64%) had not. The epilepsy worry scores for
these 50 AYAs were standardized and the distribution is shown in Figure 5.3. The
distribution of epilepsy worry scores was highly skewed to the right with a skewness of
1.0. Considering epilepsy worry based on remission status, 22% of AYAs who have
achieved 5-year seizure freedom experienced epilepsy worry, while 70% of AYAs who
have not achieved 5-year seizure freedom experienced seizure worry.
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Figure 5.3: Distribution of standardized epilepsy worry score for AYAs who
experienced epilepsy worry at the 10-year follow-up.
Table 5.5 summarizes the results of the bivariate analyses. AYAs who were female (OR =
2.50, 95% CI: 1.20, 5.20), older (OR = 1.18, 95% CI: 1.02, 1.36), and who were currently
treated by AEDs (OR = 9.58, 95% CI: 1.34, 3.17) have higher odds of experiencing
epilepsy worry, while having achieved 5-year seizure freedom (OR = 0.14, 95% CI: 0.06,
0.30) and lower epilepsy severity (OR = 0.58, 95% CI: 0.38, 0.87) were associated with
lower odds of experiencing epilepsy worry. Of the family variables, AYAs who were in
families that had more resources (OR = 0.96, 95% CI: 0.93, 1.00) and better functioning
(OR = 0.90, 95% CI: 0.81, 0.98) have lower odds of experiencing epilepsy worry. Among
AYAs who did experience epilepsy worry, having achieved 5-year seizure freedom was
significantly associated with a 0.31 times reduction (95% CI: 0.18, 0.53) in the levels of
epilepsy worry, while current use of AEDs was significantly associated with 4.18 times
increase (95% CI: 2.61, 6.70) in the levels of epilepsy worry.
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Table 5.6 summarizes the results of the multivariable analyses. Of the variables included
in the models, only 5-year seizure freedom (OR = 0.26, 95% CI: 0.08, 0.89) and current
use of AEDs (OR = 4.52, 95% CI: 1.12, 18.32) were significantly associated with the odds
of experiencing epilepsy worry, and only current use of AEDs (MR = 5.37, 95% CI: 1.94,
14.84) was associated with the level of epilepsy worry. Epilepsy severity was neither
associated with the odds of experiencing epilepsy worry (OR = 0.87, 95% CI: 0.51, 1.50)
nor the level of epilepsy worry (MR =1.01, 95% CI: 0.78, 1.32).

5.4 Results for Objective #2
Objective #2: To explore the extent to which epilepsy worry correlates with anxiety and
depression in AYAs with childhood-onset epilepsy.
The correlations between AYA epilepsy worry and anxiety and between AYA epilepsy
worry and depression were assessed using point-biserial correlation and Pearson
correlation. Complete-case analysis was conducted, as complete data were available for
both epilepsy worry and depression, and only 3 out of 130 (2.3%) values in anxiety were
missing. AYA anxiety had a weak positive correlation with the presence (r = 0.28, p <
0.05) and the level (r = 0.14, p > 0.05) of epilepsy worry. AYA depression had a moderate
positive correlation with the presence (r = 0.41, p < 0.05) and the level (r = 0.52, p <
0.05) of epilepsy worry. Lastly, a strong positive correlation was found between anxiety
and depression (r = 0.76, p < 0.05).

5.5 Results for Objective #3
Objective #3: To explore the extent to which parents of AYAs with childhood-onset
epilepsy experience worries regarding their child's health, and whether it mediates the
effect of epilepsy severity on AYAs’ epilepsy worry.
The distribution of the parents’ worry scores is presented in Figure 5.4. At the 8-year
follow-up, the parents had a mean score of 69.5 (SD = 26.3) on the parental impact –
emotional subscale. The scores ranged from 0 to 100, and 50% of the parents scored at
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or above 75. Bivariate analysis with epilepsy worry indicated that parents’ worry at the
8-year follow-up was not significantly associated with the odds of experiencing epilepsy
worry in AYAs at the 10-year follow-up (OR = 1.00, 95% CI: 0.98, 1.01). On the other
hand, higher scores on the parental impact – emotional subscale score, which is
indicative of less parents’ worry, were significantly associated with lower levels of
epilepsy worry, with 1 unit increase on the parental impact – emotional subscale score
being associated with 0.99 times reduction in the epilepsy worry score (95% CI: 0.98,
1.00).

Figure 5.4: Distribution of parents’ scores on the parental impact – emotional
subscale at the 8-year follow-up.
Mediation analysis was conducted to assess the mediating effect of parents’ worry on
the association between epilepsy severity and epilepsy worry, and the results are
presented in Tables 5.7 and 5.8. The first step to establish mediation for the Baron and
Kenny method was to assess the association between the exposure (epilepsy severity)
and the outcome (epilepsy worry). The association with adjustments for covariates was
examined in objective one, and epilepsy severity was neither associated with the odds
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of experiencing epilepsy worry (OR = 0.87, 95% CI: 0.51, 1.50) nor the level of epilepsy
worry (OR =1.01, 95% CI: 0.78, 1.32). The second step to establish mediation was to
assess the association between the exposure (epilepsy severity) and the mediator
(parents’ worry), which was found to be not significant (b = 2.12, 95% CI: -2.43, 6.66)
from the results of regression analysis. The third step to establish mediation was to
assess the association between the mediator (parents’ worry) and the outcome
(epilepsy worry). Parents’ worry was neither associated with the odds of AYAs’ epilepsy
worry (OR = 1.01, 95% CI: 0.99, 1.04) nor the level of epilepsy worry (MR = 0.99, 95% CI:
0.98, 1.00).
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Table 5.1: AYA characteristics at the 10-year follow-up (n = 130).
AYA sex, n (%)
Male
Female
AYA age, mean (SD), [range]

62 (47.7)
68 (52.3)
17.8 (2.6), [12-23]

Time since last seizure, n (%)
Less than 6 months ago
6 months ago to less than 1 year ago
1 year ago to less than 2 years
2 years ago to less than 5 years ago
5 years ago to less than 10 years ago
10 years ago or more
Don’t remember

14
5
7
20
60
22
1

Current used of AEDs, n (%)
Yes
No

34 (26.8)
93 (73.2)

Time since last AED, n (%)
Less than 6 months ago
6 months to less than 1 year ago
1 year to less than 2 years ago
More than 2 years ago
Never taken medication(s) for epilepsy or seizures
Don’t remember
Current epilepsy care status, n (%)
Transferred from a pediatric specialist to an adult
neurologist and was still receiving care for
epilepsy/seizures
Transferred from a pediatric specialist to an adult
neurologist but was no longer receive care for
epilepsy/seizures.
Receiving care from a pediatric specialist
Receiving care from a family doctor/general practitioner.
Was not receiving care for epilepsy/seizures from any
doctors now.
None of the above
AYA, adolescent and young adult; AED, anti-epileptic drug.

2
0
2
61
11
13

(10.1)
(3.9)
(5.4)
(15.5)
(46.5)
(17.1)
(0.8)

(2.3)
(0)
(2.3)
(68.5)
(12.4)
(14.6)

18 (14.2)
3 (2.4)
10 (7.9)
5 (3.9)
80 (63.0)
10 (7.9)
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Table 5.2: AYA clinical characteristics at the 2-year follow-up (n = 119).
Epilepsy severity, mean (SD)
Epilepsy severity, n (%)
1 = Extremely severe
2 = Very severe
3 = Quite severe
4 = Moderately severe
5 = Somewhat severe
6 = A little severe
7 = Not at all severe
Seizure type, n (%)
Generalized
Partial
Undetermined

6.3 (1.1)
0
2
2
6
8
29
71

(0)
(1.7)
(1.7)
(5.1)
(6.8)
(24.6)
(60.2)

45 (40.2)
63 (56.3)
4 (3.6)

Behaviour comorbidities, n (%)
Yes
No

17 (14.3)
102 (85.7)

Cognitive comorbidities, n (%)
Yes
No

24 (20.2)
94 (79.0)

AYA, adolescent and young adult.
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Table 5.3: Parent and family characteristics at the 10-year follow-up (n = 120).
Parents’ age, mean (SD)

48.8 (5.2)

Parents’ depressive symptoms, mean (SD)
CES-D score ³ 16, n (%)
CES-D score < 16, n (%)

10.1 (8.9)
27 (22.5)
93 (77.5)

Parents’ marital status, n (%)
Married
Widowed
Divorced
Seperated
Remarried
Never married

96
1
9
7
3
4

(80.0)
(0.8)
(7.5)
(5.8)
(2.5)
(3.3)

Family income, n (%)
Less than $50,000
$50,000 - $99,999
$100,000 - $149,000
$150,000 or more
Don't know

19
38
28
32
2

(16.0)
(31.9)
(23.5)
(26.9)
(1.7)

Family resources, mean (SD)

51.7 (11.9)

Family demands, mean (SD)

8.4 (5.9)

Family adaptation, mean (SD)
CES-D, Centre for Epidemiological Studies Depression Scale.

14.6 (4.0)
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Table 5.4: Attrition analysis (baseline characteristics).
Characteristics

Lost to follow-up
(n = 243)

AYA sex, n (%)
Male
Female

133 (54.73)
110 (45.27)

AYA age, mean (SD)

Completed follow-up
(n = 130)

p-value

62 (47.7)
68 (52.3)

0.20

7.37 (2.30)

7.63 (2.41)

0.30

Epilepsy severity, mean (SD)

5.32 (1.22)

5.56 (1.10)

0.07

Seizure type, n (%)
Generalized
Partial
Undetermined

89 (36.63)
146 (60.08)
5 (2.06)

54 (41.54)
74 (56.92)
2 (1.54)

Behaviour comorbidities, n (%)
Yes
No

44 (18.11)
196 (80.66)

12 (9.23)
117 (90.00)

0.01

Cognitive comorbidities, n (%)
Yes
No

65 (26.75)
174 (71.60)

9 (6.92)
121 (93.08)

<0.0001

0.61

Parents’ age, mean (SD)

37.07 (6.39)

38.85 (5.37)

0.007

Parents’ depressive symptoms,
mean (SD)

15.35 (10.60)

12.31 (9.48)

0.007

Parents’ worry, mean (SD)

44.40 (28.25)

50.71 (26.62)

0.04

Parents’ marital status, n (%)
Currently married
Not currently married

190 (78.19)
53 (21.81)

111 (85.38)
19 (14.62)

0.09

Family income, n (%)
Less than $50,000
$50,000 - $99,999
$100,000 - $149,000
$150,000 or more

60
109
13
43

(24.69)
(44.86)
(5.35)
(17.70)

18
63
7
37

(13.85)
(48.46)
(5.38)
(28.46)

0.02

Family resources, mean (SD)

48.70 (11.12)

52.61 (10.76)

0.001

Family demands, mean (SD)

10.00 (6.92)

8.55 (5.61)

0.04

Family adaptation, mean (SD)

13.68 (3.66)

14.33 (3.89)

0.11

AYA, adolescent and young adult.
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Table 5.5: Bivariate analysis of epilepsy worry with clinical, demographic, and family
characteristics.
Presence of epilepsy worry
Variable

Level of epilepsy worry

Odds ratio (SE)

95% CI

Mean ratio (SE)

95% CI

AYA sex
(ref = male)

2.50 (0.93)*

1.20, 5.20

0.88 (0.26)

0.49, 1.58

AYA age

1.18 (0.09)*

1.02, 1.36

1.08 (0.06)

0.97, 1.20

5-year seizure
freedom
(ref = no)

0.14 (0.06)*

0.06, 0.30

0.31 (0.09)*

0.18, 0.53

AED use
(ref = no)

9.58 (4.44)*

3.86, 23.74

4.18 (1.01)*

2.61, 6.70

Epilepsy severity

0.58 (0.12)*

0.38, 0.87

0.88 (0.09)

0.72, 1.08

Seizure type
(ref = generalized)

1.24 (0.42)

0.64, 2.41

0.92 (0.22)

0.57, 1.48

Behaviour
comorbidities
(ref = no)

0.91 (0.48)

0.33, 2.54

1.55 (0.63)

0.70, 3.45

Cognitive
comorbidities
(ref = no)

0.96 (0.44)

0.39, 2.37

0.91 (0.32)

0.46, 1.81

Parents’ age

1.04 (0.04)

0.97, 1.12

1.00 (0.03)

0.95, 1.06

Parents’ depressive
symptoms

1.03 (0.02)

0.99, 1.08

1.01 (0.01)

0.98, 1.04

Parents’ marital
status
(ref = not currently
married)

0.57 (0.27)

0.22, 1.45

0.69 (0.24)

0.34, 1.38

Family income
(ref = <50,000)

0.77 (0.14)

0.54, 1.11

1.06 (0.16)

0.79, 1.43

Family resources

0.96 (0.02)*

0.93, 1.00

0.98 (0.01)

0.95, 1.01

Family demands

1.03 (0.03)

0.97, 1.10

1.02 (0.03)

0.96, 1.07

Family adaptation

0.90 (0.04)*

0.81, 0.98

0.98 (0.04)

0.90, 1.07

AYA, adolescent and young adult; AED, anti-epileptic drug.
*p < 0.05
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Table 5.6: Multivariable analysis of epilepsy worry with clinical, demographic, and family
characteristics.
Presence of epilepsy worry
Variable

Level of epilepsy worry

Odds ratio (SE)

95% CI

Mean ratio (SE)

95% CI

Intercept

0.02 (0.07)

0.00, 33.42

0.16 (0.39)

0.00, 18.24

AYA sex
(ref = male)

2.05 (1.04)

0.76, 5.54

0.57 (0.21)

0.28, 1.15

AYA age

1.07 ( 0.12)

0.86, 1.33

1.01 (0.08)

0.87, 1.17

5-year seizure
freedom
(ref = no)

0.26 (0.16)*

0.08, 0.89

0.90 (0.49)

0.31, 2.62

AED use
(ref = no)

4.52 (3.23)*

1.12, 18.32

5.37 (2.79)*

1.94, 14.84

Epilepsy severity

0.87 (0.24)

0.51, 1.50

1.01 (0.14)

0.78, 1.32

Seizure type
(ref = generalized)

1.52 (0.70)

0.61, 3.77

1.36 (0.39)

0.77, 2.38

Behaviour
comorbidities
(ref = no)

0.52 (0.43)

0.10, 2.67

1.02 (0.50)

0.39, 2.69

Cognitive
comorbidities
(ref = no)

1.09 (0.72)

0.30, 4.01

1.67 (0.73)

0.71, 3.95

Parents’ age

1.04 (0.05)

0.94, 1.15

1.04 (0.04)

0.97, 1.12

Parents’ depressive
symptoms

1.02 (0.04)

0.94, 1.10

0.98 (0.02)

0.94, 1.02

Parents’ marital
status
(ref = not currently
married)

0.89 (0.61)

0.23, 3.44

0.87 (0.39)

0.36, 2.11

Family income
(ref = <50,000)

0.79 (0.23)

0.45, 1.38

1.17 (0.19)

0.86, 1.60

Family resources

1.02 (0.04)

0.95, 1.10

0.99 (0.02)

0.95, 1.03

Family demands

1.00 (0.05)

0.90, 1.11

0.99 (0.04)

0.92, 1.06

Family adaptation

0.95 (0.07)

0.81, 1.11

0.95 (0.05)

0.86, 1.04

AYA, adolescent and young adult; AED, anti-epileptic drug.
*p < 0.05
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Table 5.7: Analysis of parents’ worry mediation effect (exposure à mediator).
Variable
Intercept
AYA sex
(ref = male)

Coefficient (SE)

95% CI

3.52 (38.26)

-72.48, 79.52

-2.63 (4.94)

-12.43, 7.17

0.88 (1.01)

-1.13, 2.89

16.32 (5.97)*

4.49, 28.15

AED use
(ref = no)

6.35 (7.10)

-7.73, 20.43

Epilepsy severity

2.12 (2.29)

-2.43, 6.66

Seizure type
(ref = generalized)

3.76 (4.17)

-4.52, 12.04

Behaviour comorbidities
(ref = no)

3.10 (7.47)

-11.73, 17.93

Cognitive comorbidities
(ref = no)

-17.73 (6.48)*

-30.61, -4.86

Parents’ age

0.19 (0.47)

-0.74, 1.13

Parents’ depressive symptoms

0.06 (0.46)

-0.85, 0.97

Parents’ marital status
(ref = not currently married)

1.38 (6.04)

-10.60, 13.37

-4.37 (2.87)

-10.07, 1.33

AYA age
5-year seizure freedom
(ref = no)

Family income
(ref = <50,000)
Family resources

0.68 (0.34)*

0.01, 1.36

Family demands

-0.35 (0.53)

-1.40, 0.70

Family adaptation

-0.43 (0.74)

-1.90, 1.03

AYA, adolescent and young adult; AED, anti-epileptic drug.
*p < 0.05
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Table 5.8: Analysis of parents’ worry mediation effect (mediator à outcome).
Presence of epilepsy worry
Variable

Level of epilepsy worry

Odds ratio (SE)

95% CI

Mean ratio (SE)

95% CI

Intercept

0.02 (0.07)

0.00, 36.98

0.27 (0.64)

0.00, 27.87

Parents’ worry

1.01 (0.01)

0.99, 1.04

0.99 (0.01)

0.98, 1.00

AYA sex
(ref = male)

2.11 (1.08)

0.78, 5.76

0.54 (0.19)

0.27, 1.07

AYA age

1.06 (0.12)

0.85, 1.31

1.01 (0.07)

0.88, 1.16

5-year seizure
freedom
(ref = no)

0.21 (0.14)*

0.06, 0.77

1.05 (0.55)

0.38, 2.94

AED use
(ref = no)

4.30 (3.09)*

1.05, 17.55

5.18 (2.55)*

1.97, 13.61

Epilepsy severity

0.85 (0.24)

0.49, 1.46

1.06 (0.14)

0.82, 1.37

Seizure type
(ref = generalized)

1.47 (0.69)

0.59, 3.67

1.27 (0.36)

0.73, 2.20

Behaviour
comorbidities
(ref = no)

0.46 (0.40)

0.09, 2.51

1.16 (0.55)

0.46, 2.93

Cognitive
comorbidities
(ref = no)

1.49 (1.10)

0.35, 6.37

1.25 (0.57)

0.51, 3.06

Parents’ age

1.04 (0.06)

0.94, 1.16

1.04 (0.04)

0.97, 1.11

Parents’ depressive
symptoms

1.02 (0.04)

0.94, 1.10

0.98 (0.02)

0.94, 1.02

Parents’ marital
status
(ref = not currently
married)

0.87 (0.60)

0.22, 3.34

0.98 (0.43)

0.42, 2.32

Family income
(ref = <50,000)

0.82 (0.24)

0.46, 1.45

1.13 (0.17)

0.83, 1.53

Family resources

1.01 (0.04)

0.94, 1.09

1.00 (0.02)

0.96, 1.04

Family demands

1.00 (0.05)

0.91, 1.11

0.99 (0.03)

0.92, 1.05

Family adaptation

0.95 (0.08)

0.81, 1.11

0.94 (0.05)

0.85, 1.04

AYA, adolescent and young adult; AED, anti-epileptic drug.
*p < 0.05
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Chapter 6

6

Discussion

This chapter discusses the findings of this thesis. Section 6.1 provides a summary of the
findings by objective and the interpretation of the findings. Sections 6.2 and 6.3 discuss
the strengths and limitations of this thesis. Section 6.4 proposes recommendations for
future research, and section 6.5 concludes the chapter by discussing the implications of
the study findings.

6.1 Summary of Findings
The purpose of this thesis was to explore the extent to which AYAs with childhood-onset
epilepsy experience epilepsy worry 10 years after their epilepsy diagnosis, and to assess
the relationship between epilepsy worry and AYAs’ clinical, demographic, and family
characteristics. In addition, this thesis examined the correlations between epilepsy
worry, anxiety, and depression among AYAs, and assessed the potential mediating effect
of parents’ worry on their AYA’s epilepsy worry.

6.1.1

Objective #1

The first objective of this thesis was to describe the extent to which AYAs with
childhood-onset epilepsy experience epilepsy worry, and to explore its associations with
epilepsy severity and other clinical, demographic, and family characteristics. Due to the
unpredictable nature of seizures, people with epilepsy could experience a heightened
sense of apprehension regarding the occurrence of future seizures and the related
consequences, possibly even after seizure remission. In this study, it was found that
nearly 40% of AYAs had experienced at least some epilepsy worry within the past four
weeks at the 10-year follow-up. More than one-third of AYAs who had experienced
epilepsy worry had achieved 5-year seizure freedom. When considering epilepsy worry
based on remission status, about a fifth of AYAs who have achieved 5-year seizure
freedom experienced epilepsy worry. The finding that AYAs continue to experience
epilepsy worry after remission is consistent with what we expected, as well as with past
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literature. In a study of the long-term psychological function in people with childhoodonset temporal lobe epilepsy 13 years after their first seizure, the authors found that
77% of the individuals in remission still experienced lingering worry about possible
seizure recurrence (112). The higher proportion compared to our findings (77% vs 22%)
may be due the differently defined seizure freedom status—the authors of this study
defined seizure freedom as being free of seizures and AEDs for two or more years,
whereas our study used 5-year seizure freedom as the cut-off point. The longer duration
of seizure freedom in our study could allow AYAs more time to adjust to their remission
status and outgrow their worry about epilepsy. Micallef and colleagues (112) also found
that the proportion of people who were both experiencing epilepsy worry and were in
remission was higher compared to those who had undergone epilepsy surgery and were
either seizure-free or not, suggesting that the lingering epilepsy worry may be due to
their spontaneous seizure remission not offering the same level of reassurance that
their condition has been cured as compared to the surgical groups. This lack of
reassurance may cause people to worry more about potential seizure recurrence and
associated consequences like injuries and stigma. These findings offer some insights on
addressing epilepsy worry—that psychological support should extend to those in seizure
remission, and reassurance should be offered to those with spontaneous remission
about the low probability of relapse to help with their psychological adjustment.
In the current study, we found that 5-year seizure freedom was associated with the
AYAs’ odds of experiencing epilepsy worry, but was not associated with the level of
epilepsy worry after adjustments for other covariates. The finding that those with
seizure freedom have lower odds of experiencing epilepsy worry is consistent with our
expectation and findings from other studies. Micallef and colleagues (112) found similar
results; a smaller proportion of people with childhood-onset temporal lobe epilepsy
who had been seizure-free for two or more years experienced epilepsy worry, compared
to those with ongoing seizures. In another study that prospectively followed children
with epilepsy for 8 to 9 years after the initial epilepsy diagnosis, the authors found that
having achieved 5-year seizure freedom at the follow-up was associated with a lower
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risk of reporting internalizing problems, mainly depression and anxiety (113). This
association is likely because AYAs who have been seizure-free for a long period of time
are likely less or no longer affected by epilepsy in many domains of their lives, therefore
are no longer worried about their condition and its impact. This interpretation is
supported by other studies. One study found that adults with seizure freedom reported
lower levels of illness intrusiveness and increased perceived control, self-esteem, and
epilepsy specific QoL compared to those with ongoing seizures (114). Another study
found that people who have longer duration of seizure remission have lower severity of
subjective handicap, which the authors speculate could be reflective of increasing
confidence that their epilepsy is resolved (115).
Our finding that 5-year seizure freedom was not associated with the level of epilepsy
worry was unexpected. There are a few possible reasons for the insignificant
association. First, this thesis examined 5-year seizure freedom as opposed to a more
detailed measure of time since last seizure, such as in the works of O’Donoghue and
colleagues (115). The possible association between duration of seizure remission and
the level of epilepsy worry may have been lost with the dichotomization of the variable.
Secondly, the subgroup that experienced epilepsy worry and was used for the analysis
of the level of epilepsy worry had a small sample size—only 50 out of 130 AYAs in our
sample experienced epilepsy worry at the 10-year follow-up. Although it is a positive
outcome that the majority of AYAs did not experience epilepsy worry, the analysis may
be underpowered to detect a significant effect due to the small sample size. Lastly, most
AYAs in our sample have mild epilepsy severity or have outgrown their epilepsy, which
continues to be the case when limiting attention to those experiencing epilepsy worry,
and the distribution for the scores for epilepsy worry level was highly skewed to the
right, suggesting that among AYAs who did experience epilepsy worry, the levels of
epilepsy worry were low. As such, there may be insufficient variation in our data to
detect an association.
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This study also investigated the potential effects of AED use on epilepsy worry and
found that AYAs who were currently using AEDs have higher odds of experiencing
epilepsy worry and have higher levels of epilepsy worry. It is well recognized that
various AEDs could initiate or worsen already existing behavioral or psychiatric
problems. Many different AED options are available to treat epilepsy, and each option
has its own possible adverse effects (33,116). For example, children with epilepsy who
are being treated with levetiracetam have a higher risk of developing aggression,
hostility, and nervousness compared to those who were on placebo (117). It is possible
that for the AYAs who were currently using AEDs, the side-effects of AEDs may have
altered their mood and thereby initiated or worsened their epilepsy worry.
Unfortunately, HERQULES did not have data concerning the types of AED prescriptions
that the AYAs were receiving, and the number of AYAs who were on AEDs at the 10-year
follow-up (34 out of our sample of 130 AYAs) was too small to produce reliable results,
especially when considering the many AED options available.
Another possible explanation for the association between AED treatment and epilepsy
worry could be that the continuation of treatment is perceived as persisting epilepsy,
even when the person has been seizure-free for some time. One study followed people
with childhood-onset epilepsy for more than 30 years and found that those in remission
but still taking AEDs have similar QoL compared to those not in remission, and both
groups have significantly lower QoL scores compared to those in remission and
discontinued AEDs (118). Both the behavioural and psychiatric side-effects of AEDs and
the perception of lingering epilepsy that arose from continuing AED treatment could
contribute to the lowered QoL, despite being in remission. Another study randomized
people who had been in seizure remission for two years to either continue their AED
treatment or slowly discontinue their AED treatment (119). This study found that those
who discontinued AED treatment were less likely to worry about epilepsy or feel
restricted by epilepsy than those with continued treatment, which is consistent with our
results. The same study also found that people who discontinued AED treatment felt
less internalized stigma and fewer restrictions on their social activities compared to
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those with continued treatment, suggesting that the successful discontinuation of AEDs
allow people with prior epilepsy to adopt the mindset that they have outgrown their
epilepsy and are free from recurrent seizures and the stigma associated with epilepsy.
In our study, the hypothesized stressor, epilepsy severity two years after diagnosis, was
not found to be associated with either the presence or the level of epilepsy worry 10
years after diagnosis in AYAs with childhood-onset epilepsy. Previous studies have
examined epilepsy severity as a risk factor in children or adolescents with childhoodonset epilepsy and found that more severe epilepsy was associated with adverse
outcomes such as poorer QoL (120), more emotional problems and depression (121),
poorer self-esteem (122), and poorer emotional well-being (79). The finding of the
insignificant association between epilepsy severity and epilepsy worry in this thesis
could be due the overall mild epilepsy severity in the sample, even at two years postdiagnosis, and the mild severity may not have strongly affected the psychological
development and well-being of these AYAs. This is supported by the findings from a
review on the psychopathology and psychological adjustment in children and
adolescents with epilepsy (121). The review found that epilepsy-related factors were
significant risk factors for psychopathology in children with more severe epilepsy or
poorer seizure control, but were not related to psychological and adaptation problems
in children with less severe epilepsy or good seizure control.
Another possible explanation for the insignificant association between epilepsy severity
and epilepsy worry is that an inadequate proxy may have been chosen to represent the
stress and burden of a diagnosis of epilepsy and living with epilepsy. The variable chosen
to represent the stress and burden was epilepsy severity two years post-diagnosis,
which may not have adequately reflected the level of stress that the child and the family
are required to take on with the child’s epilepsy. For example, how well the child’s
seizures are controlled or how much the child’s epilepsy severity has changed (either
improved or worsened) over time could both contribute to the burden of living with
epilepsy, but may not have been captured by the epilepsy severity proxy.
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6.1.2

Objective #2

The second objective for this thesis was to explore the extent to which epilepsy worry
correlates with anxiety and depression in AYAs with childhood-onset epilepsy. It is well
recognized that anxiety and depression often co-occur, and these two conditions are
prevalent in people with epilepsy. Worry is also often interpreted as the same construct
as anxiety, and has been shown to be associated with both anxiety and depression in
past studies (21,86,87), as well as in people with epilepsy (37,123). Examining the extent
of correlation between the constructs of epilepsy worry, anxiety, and depression in
people with epilepsy could help inform whether epilepsy worry is a separate construct
that requires its own attention instead of being viewed as a part of anxiety or
depression.
In our study, a strong positive correlation was found between anxiety and depression,
which is consistent with our expectations, and provides additional evidence supporting
the associations between these two conditions in epilepsy. Although highly correlated,
anxiety and depression have been found to impact QoL differently in people with
epilepsy (123,124). In terms of epilepsy worry, this thesis found that epilepsy worry had
a weak positive correlation with anxiety and a moderate positive correlation with
depression. Several other studies have examined the associations between epilepsy
worry, measured using versions of QOLIE, and anxiety and depression in people with
epilepsy. Two studies found that epilepsy worry was associated with anxiety but not
with depression (124,125), and another study found that both anxiety and depression
were associated with epilepsy worry, with anxiety having a stronger association (123).
The differences in the strength of the correlation or associations may be due to
differences in the instruments used to measure anxiety and depression in these studies,
as instruments for the same constructs sometimes have variations and are not always
interchangeable. The low or moderate correlations between epilepsy worry and
anxiety/depression suggest that at least part of epilepsy worry is distinct from anxiety
and from depression, although more evidence is needed to support this interpretation.
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The weak correlation between epilepsy worry and anxiety found in the current study
suggests a small overlap between these two constructs. Previous literature has
attempted to differentiate between worry and anxiety by ascribing somatic responses to
anxiety and cognitive processes to worry (22,24). It could be that the instrument used to
measure anxiety in our study (STAI: Y-6) places more focus on the somatic responses,
therefore resulting in a weak correlation with the cognitive processes of worrying about
epilepsy.

6.1.3

Objective #3

The third and final objective for this thesis was to explore the extent to which parents of
AYAs with childhood-onset epilepsy experience worry regarding their child's health, and
whether it mediates the effect of epilepsy severity on AYAs’ epilepsy worry. Due to the
many adverse effects of epilepsy, parents of children with epilepsy may express
heightened worry and concern about their child and adopt an over-protective parenting
style, which in turn influences their child’s psychosocial development and well-being
(66,67,69). In this thesis, it was found that the level of parents’ worry regarding their
child’s health eight years after epilepsy diagnosis was low overall. The parents’ worry
was not a risk factor for the AYAs’ epilepsy worry, nor did it mediate the effect of the
AYAs’ epilepsy severity on AYAs’ epilepsy worry. The mild levels of parental worry and
the insignificant associations or mediating effects in the findings may again be due to
the fact that the majority of AYAs in the sample have fairly mild epilepsy severity, which
may not have strongly impacted the AYAs’ functioning and family environment, thereby
lessening the parents’ caregiving stress and level of worry. This interpretation is
supported by previous studies: One study found that parents of children with poorly
controlled epilepsy had lower QOL, higher levels of anxiety, and higher levels of
depression compared to parents of children with well-controlled epilepsy (58), and
another study found that families of children experiencing more frequent seizures had
higher levels of family stress compared to those who had less frequent seizures or had
no chronic illness (126). The low variation in the AYAs’ level of epilepsy worry and
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epilepsy severity may have also contributed to the insignificant associations with and
mediating effects of parents’ worry.

6.2 Strengths
This thesis has several strengths. This is the first study to the best of our knowledge that
focused on epilepsy worry among people with childhood-onset epilepsy a decade after
their epilepsy diagnosis and examined the possible risk factors. The majority of the AYAs
in our sample had been seizure-free for at least five years, which is consistent with the
course of epilepsy (7). This thesis made use of the prospective nature of the data from
HERQULES to allow temporality between exposure, mediator, and outcome variables.
The exposures and mediator assessed in this thesis were all measured using validated
instruments. Lastly, HERQULES contained multiple waves of follow-up which reduced
the risk of recall bias.

6.3 Limitations
There are some limitations to this thesis. First, this thesis is a secondary analysis—
HERQULES data were originally collected with the primary objective to assess HRQoL in
children with epilepsy and the associated risk factors (83) other than epilepsy worry. As
such, the study did not collect all potential risk factors of epilepsy worry (e.g., parents’
anxiety, parenting style). Also, as most of the AYAs in the sample had mild epilepsy
severity and none of the AYAs had surgical treatment, the generalizability of this study is
limited to those with childhood-onset epilepsy and not those with more severe forms of
epilepsy or drug-resistant epilepsy. There were some significant differences between
the families retained in the study and the families lost to follow-up, with most of the
differences indicating that the families lost to follow-up fared worse on child co-morbid
problems, parents’ psychological well-being, and family environment. The loss of
variability among these factors lowered the likelihood of finding significant effects of
these variables on the outcome. The sample size of this study may have also been
underpowered to detect a significant effect, especially concerning the analysis regarding
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the level of epilepsy worry among those who experienced epilepsy worry. Lastly, the
tool used to measure epilepsy worry was not optimal. Requiring different ageappropriate versions of an instrument for specific age groups is a common challenge in
long-term prospective studies. Two different versions of the QOLIE instrument, one for
adolescents aged 11-17 and one for young adults aged 18 or older, were used in the
questionnaires for the AYAs in HERQULES. Due to some differences in the questions
included in the seizure worry sections for these two versions of QOLIE, only select items
were used to generate a common score for epilepsy worry. The validity and reliability of
the outcome measure, as well as comparability to other studies, may have been
impacted by this process. In addition, worry related to seizures are not limited to future
seizures or injuries as epilepsy worry was measured in this thesis, but can also include
other areas such as social embarrassment and future outcomes. Unfortunately, there is
an absence of a standard definition and description of specific elements that should be
included in the assessment of epilepsy worry, and the effort to produce a standard
definition could be complicated by the diverse etiology and clinical characteristics of
epilepsy.

6.4 Recommendations for Future Research
Future research on worry related to epilepsy and seizures should prioritize the task of
standardizing the term used to refer to this construct and the included elements. A
comprehensive systematic review and additional structured interviews could aid in the
development of a gold standard instrument for assessing epilepsy worry. Age group
differences should be taken into consideration when developing the instrument, as
people at different life stages place importance on different aspects of life. With the
development of an instrument, future studies could consider examining epilepsy worry
starting at epilepsy diagnosis to observe its trajectory and identify possible risk and
protective factors. Future studies using a larger sample size could examine the
association between the presence and level of epilepsy worry and various risk factors
that this thesis was underpowered to assess or risk factors that were not included in this
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thesis (e.g., type of AED). Future studies could also investigate the effect of providing
reassurance to those in remission but on AEDs on reducing epilepsy worry. It would also
be helpful to examine the potential positive effects of epilepsy worry—for example, an
adequate level of worry toward epilepsy may help people avoid seizure triggers and
adhere to their treatment regimens. Although the current study did not find an
association between epilepsy severity and epilepsy worry, future studies could consider
examining whether change in epilepsy severity can influence epilepsy worry. Lastly,
continued research on improving treatment options for epilepsy are warranted to work
toward the treatment goal of a seizure-free status without adverse effects.

6.5 Implications and Conclusions
In summary, this thesis found that the majority of AYAs reported at the 10-year followup that they had not experienced any epilepsy worry within the past four weeks, but
more than one-third reported that they had experienced at least some epilepsy worry.
Five-year seizure freedom status and currently taking AEDs were risk factors for the
AYAs’ epilepsy worry 10 years after their diagnosis of epilepsy in childhood. This thesis
also found that epilepsy worry was weakly and moderately correlated with anxiety and
depression, respectively. More detailed investigations are needed with additional
information on the AEDs and their effects to understand the relationship between AED
use and epilepsy worry. Although AYAs who did not gain control of their seizures have
higher odds of experiencing epilepsy worry, healthcare professionals may consider
examining AYAs in remission to identify those who still worry about their epilepsy and
offer reassurance about their condition. The finding that epilepsy worry was not
strongly correlated with anxiety or depression suggest that it could be examined and
addressed as its own aspect of mental health in people with epilepsy, both in research
and clinical practices, although more research is needed to support this argument.
Identifying people who are worried about their epilepsy could also help identify those
who are at risk for factors previously been found to be associated with epilepsy worry,
such as attitude toward illness, internalized stigma, and self-efficacy in managing

61

seizures, with an aim toward targeting intervention efforts. Lastly, although parent and
family factors were not found to affect AYAs’ epilepsy worry, these factors still play an
important role in the child’s development and well-being, and should continue to be
considered in future research regarding the mental health of people with childhoodonset epilepsy.
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Appendix A: Physician FormAPPENDIX A: PHYSICIAN FORM
Patient’s Date of Birth (dd/mm/yy): __________

Site #:_____________

Please answer the following questions based on information from this patient’s most
recent visit and return upon completion

1.

Date of patient’s last visit (dd/mm/yy): _______________ or Date of Telephone F/U
(dd/mm/yy)____________

2.

Date form completed (dd/mm/yy): _________________

If information for 3 thru 7 is unchanged from baseline (diagnosis) visit, please check here
and proceed to 8.
3. Seizure type(s):

1) ______________________

2)________________________

3)______________________

4)________________________

4. Epilepsy syndrome: _________________________
5. Convulsive status epilepticus:
No
Yes
6. Exclusive nocturnal seizures:
No
Yes
7.

Age of first seizure (excluding febrile seizure): _______ yrs

8. Does this patient have any family with epilepsy?
No
Yes
9. Number of AEDs currently: ________
10. Number of AEDs total: ________
11. Is this patient of school age?
No
Yes → Grade: ___

regular class

regular class with resource

special class
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12. Does the patient have behavioural problems?
No (normal)
Yes → Please check one:

mild

moderate

severe

Diagnosis: _____________________
13. Does the patient have cognitive problems?
No (normal)
Yes → Please check one:

borderline

mild

moderate

severe

Diagnosis: ______________________
14. Does this patient have motor problems?
No
Yes → Please check one:

mild

moderate

severe

Diagnosis: ______________________
15. Other neurological deficits? Please specify: ______________________________________
______________________________________
16. Taking into account all aspects of this patient’s epilepsy, how would you rate its severity at
his/her last visit? Please check one answer.
Extremely severe
Very severe
Quite severe
Moderately severe
Somewhat severe
A little severe
Not at all severe
17. Rate the following aspects of this patient’s epilepsy at his/her last visit.
Check one box using the following 7-point scale:
1 = none or never
7 = extremely frequent, severe or high
1
Frequency of seizures
Intensity of seizures
Falls or injuries during seizures
Severity of post-ictal period
Amount of antiepileptic drugs
Side effects of antiepileptic drugs
Interference of epilepsy or drugs with daily activities

2

3

4

5

6

7
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Appendix B: AYA Questionnaire Measurement Tools
Spielberger State-Trait Anxiety Inventory short-form (STAI: Y-6)
A number of statements which people have used to describe themselves are given below. Read
each statement and then circle the most appropriate number to the right of the statement to
indicate how you feel right now, at this moment. There are no right or wrong answers. Do not
spend too much time on any one statement but give the answer which seems to describe your
present feelings best.
Not at all

Somewhat

Moderately

Very much

a) I feel calm

1

2

3

4

b) I am tense

1

2

3

4

c) I feel upset

1

2

3

4

d) I am relaxed

1

2

3

4

e) I feel content

1

2

3

4

f) I am worried

1

2

3

4
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Centre for Epidemiological Studies Depression Scale (CES-D)
Please read these sentences that say something about how people sometimes feel and circle the
number of the category on this page that best indicates how often you have felt this way in the
past 7 days.
Rarely or none
of the time
(less than 1
day)
a) I was bothered by things
that usually don’t bother me.
b) I did not feel like eating; my
appetite was poor.
c) I felt that I could not shake
off the blues even with help
from my family or friends.
d) I felt that I was just as good
as other people.
e) I had trouble keeping my
mind on what I was doing.

During the Past Week:
Occasionally or
Some or a little
a moderate
of the time (1amount of time
2 days)
(3-4 days)

Most or all of
the time (5-7
days)

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

£

j) I felt fearful.

£

£

£

£

k) My sleep was restless.

£

£

£

£

l) I was happy.

£

£

£

£

m) I talked less than usual.

£

£

£

£

n) I felt lonely.

£

£

£

£

o) People were unfriendly.

£

£

£

£

p) I enjoyed life.

£

£

£

£

q) I had crying spells.

£

£

£

£

r) I felt sad.

£

£

£

£

s) I felt that people dislike me.

£

£

£

£

t) I could not get “going”.

£

£

£

£

f) I felt depressed.
g) I felt that everything I did
was an effort.
h) I felt hopeful about the
future.
i) I thought my life had been a
failure.
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Appendix C: Parent Questionnaire Measurement Tools
Family Inventory of Resources for Management (FIRM): Family Strength: Mastery and
Health and Extended Family Support Subscales
The next set of questions asks about what social, psychological, community and financial
resources families believe they have available to them in the management of family life. To
complete this inventory you are asked to read the list of “Family Statements” one at a time. In
each statement, “family” means your immediate family (mother and/or father and children.)
Then ask yourself: “How well does the statement describe our family situation?”
Then make your decision by circling one of the following:
0 = Not At All
1 = Minimally
2 = Moderately
3 = Very Well

This statement does not describe our family situation. This
does not happen in our family.
This statement describes our family situation only slightly. Our
family may be like this once in a while.
This statement describes our family situation fairly well. Our
family is like this some of the time.
This statement describes our family very accurately. Our family
is like this most of the time.

Moderately

Very Well

a. Being physically tired much of the time is a problem in our family
b. We have to nag each other to get things done
c. We do not plan too far ahead because many things turn out to be
a matter of good or bad luck anyway
d. Having only one person in the family earning money is (or would
be) a problem in our family
e. It seems that members of our family take each other for granted
f. Sometimes we feel we don’t have enough control over the
direction our lives are taking
g. Certain members of our family do all the giving, while others do
all the taking
h. We seem to put off making decisions
i. Our family is under a lot of emotional stress
j. Many things seem to interfere with family members being able to
share concerns
k. Most of the money decisions are made by only one person in our
family
l. It seems that we have more illness (colds, flu, etc.) in our family
than other people do

Minimally

Family Statements:

Not at all

Please read and record your decision for each of the statements below.

0
0

1
1

2
2

3
3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0
0

1
1

2
2

3
3

0

1

2

3

0

1

2

3

0

1

2

3

Moderately

Very Well

m. In our family some members have many responsibilities while
others don’t have enough
n. It is upsetting to our family when things don’t work out as
planned
o. Being sad or “down” is a problem in our family
p. It is hard to get family members to cooperate with each other
q. Many times we feel we have little influence over the things that
happen to us
r. We have the same problems over and over – we don’t seem to
learn from past mistakes
s. There are things at home we need to do that we don’t seem to
get done
t. We seem to be so involved with work and/or school activities that
we don’t spend enough time together as a family
u. Our relatives seem to take from us, but give little in return
v. We try to keep in touch with our relatives as much as possible
w. Our relative(s) are willing to listen to your problems
x. Our relatives do and say things that make us feel appreciated

Minimally

Family Statements:

Not at all
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0

1

2

3

0

1

2

3

0
0

1
1

2
2

3
3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3
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Family Inventory of Life Events & Changes (FILE)
Over their life cycle, all families experience many changes as a result of normal growth and
development of members and due to external circumstances. The following list of family life
changes can happen in a family at any time. Because family members are connected to each
other in some way, a life change for any one member affects all the other persons in the family
to some degree.
“FAMILY” means a group of two or more persons living together who are related by blood,
marriage or adoption. This includes persons who live with you and to whom you have a long
term commitment.
Please read each family life change and decide whether it happened to any member of your
family - including you - during the past 12 months and check Yes or No.
During the
last 12
months
Did the change happen in your family:
I. Intrafamily Strains
a. Increase of husband/father’s time away from family
b. Increase of wife/mother’s time away from family
c. A member appears to have emotional problems
d. A member appears to depend on alcohol or drugs
e. Increase in conflict between husband and wife
f. Increase in arguments between parent(s) and child(ren)
g. Increase in conflict among children in the family
h. Increased difficulty in managing teenage child(ren)
i. Increased difficulty in managing school age child(ren) (6-12 yrs)
j. Increased difficulty in managing preschool age child(ren) (2.5-6 yrs)
k. Increased difficulty in managing toddler(s) (1-2.5 yrs)
l. Increased difficulty in managing infant(s) (0-1 yr)
m. Increase in the amount of “outside activities” which the children are
involved in
n. Increased disagreement about a member’s friends or activities
o. Increase in the number of problems or issues which don’t get
resolved
p. Increase in the number of tasks or chores which don’t get done
q. Increased conflict with in-laws or relatives
II. Marital Strains
a. Spouse/parent was separated or divorced
b. Spouse/parent had an “affair”
c. Increased difficulty in resolving issues with a “former” or separated
spouse
d. Increased difficulty with sexual relationship between husband and
wife

Yes

No

Score
46
51
58
66
53
45
48
55
39
36
36
35
25
35
45
35
40
79
68
47
58
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During the
last 12
months
Did the change happen in your family:
III. Pregnancy and Childbearing Strains
a. Spouse had unwanted or difficulty pregnancy
b. An unmarried member became pregnant
c. A member had an abortion
d. A member gave birth to or adopted a child
IV. Finance and Business Strains
a. Took out a loan or refinanced a loan to cover increased expenses
b. Went on welfare
c. Change in conditions (economic, political, weather) which hurts the
family investments
d. Change in agriculture market, stock market, or land values which
hurts family investments and/or income
e. A member started a new business
f. Purchased or built a home
g. A member purchased a car or other major item
h. Increased financial debts due to over-use of credit cards
i. Increased strain on family “money” for medical/dental expenses
j. Increased strain on family “money” for food, clothing, energy, home
care
k. Increased strain on family “money” for child(ren)’s education
l. Delay in receiving child support or alimony payments
V. Work-Family Transitions and Strains
a. A member changed to a new job/career
b. A member lost or quit a job
c. A member retired from work
d. A member started or returned to work
e. A member stopped working for extended period (e.g., laid off, leave
of absence, strike)
f. Decrease in satisfaction with job/career
g. A member had increased difficulty with people at work
h. A member was promoted at work or given more responsibilities
i. Family moved to a new home/apartment
j. A child/adolescent member changed to a new school
VI. Illness and Family “Care” Strains
a. Parent/spouse became seriously ill or injured
b. Child became seriously ill or injured
c. Close relative or friend of the family became seriously ill
d. A member became physically disabled or chronically ill

Yes

No

Score
45
65
50
50
29
55
41
43
50
41
19
31
23
21
22
41
40
55
48
41
51
45
32
40
43
24
44
35
44
73
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During the
last 12
months
Did the change happen in your family:
e. Increased difficulty in managing a chronically ill or disabled member
f. Member or close relative was committed to an institution or nursing
home
g. Increased responsibility to provide direct care or financial help to
husband’s and/or wife’s parents
h. Experienced difficulty in arranging for satisfactory child care
VII. Losses
a. A parent/spouse died
b. A child member died
c. Death of husband’s or wife’s parent or close relative
d. Close friend of the family died
e. Married son or daughter was separated or divorced
f. A member “broke up” a relationship with a close friend
VIII. Transitions “In and Out”
a. A member was married
b. Young adult member left home
c. Young adult member began college (or post high school training)
d. A member moved back home or a new person moved into the
household
e. A parent/spouse started school (or training program) after being
away from school for a long time
IX. Family Legal Violations
a. A member went to jail or juvenile detention
b. A member was picked up by police or arrested
c. A member ran away from home
d. A member dropped out of school or was suspended from school

Yes

No

Score
58
44
47
40
98
99
48
47
58
35
42
43
28
42
38
68
57
61
38
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Family Adaptability, Partnership, Growth, Affection and Resolve (APGAR)
Think about the following and check the answer that best describes how you feel most of the
time. Please be honest.

a) When something is bothering me, I can ask my family for help.
£

£

£

£

£

Never

Hardly

Some of
the time

Almost
always

Always

b) I like the way my family talks things over and shares problems with me.
£

£

£

£

£

Never

Hardly

Some of
the time

Almost
always

Always

c) I like how my family lets me try new things I want to do.
£

£

£

£

£

Never

Hardly

Some of
the time

Almost
always

Always

d) I like what my family does when I feel mad, happy, or loving.
£

£

£

£

£

Never

Hardly

Some of
the time

Almost
always

Always

e) I like how my family and I share time together.
£

£

£

£

£

Never

Hardly

Some of
the time

Almost
always

Always
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Appendix D: Comparison of Characteristics of Complete and Incomplete Cases
Table D-1: Comparison of AYA characteristics of complete and incomplete cases.
Characteristics
AYA sex, n (%)
Male
Female
AYA age, mean (SD)
Epilepsy worry experienced, n (%)
Yes
No
Epilepsy worry level, mean (SD)

Incomplete data
(n = 39)

Complete data
(n = 91)

15 (38.46)
24 (61.54)

47 (51.65)
44 (48.35)

17.87 (2.60)
16 (41.03)
23 (58.97)

17.80 (2.56)
34 (37.36)
57 (62.64)

p-value

0.17
0.89
0.69

0.99 (1.05)

1.00 (0.97)

0.98

AYA depression, mean (SD)

14.31 (12.18)

12.58 (10.39)

0.41

AYA anxiety, mean (SD)

38.24 (14.06)

36.56 (13.41)

0.53

5-year seizure freedom, n (%)
Yes
No

24 (64.86)
13 (35.14)

58 (63.74)
33 (36.26)

0.90

Current use of AEDs, n (%)
Yes
No

11 (30.56)
25 (69.44)

23 (25.27)
68 (74.73)

0.55

Epilepsy severity, mean (SD)

6.33 (1.00)

6.31 (1.13)

0.92

Seizure type, n (%)
Generalized
Partial
Undetermined

13 (61.90)
8 (38.10)
0 (0)

32 (35.16)
55 (60.44)
4 (4.40)

Behaviour comorbidities, n (%)
Yes
No

6 (21.43)
22 (78.57)

11 (12.09)
80 (87.91)

0.22

Cognitive comorbidities, n (%)
Yes
No

2 (7.41)
25 (92.59)

22 (24.18)
69 (75.82)

0.06

AYA, adolescent and young adult; AED, anti-epileptic drug.

0.09
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Table D-2: Comparison of parent and family characteristics of complete and incomplete
cases.
Characteristics

Incomplete data
(n = 39)

Complete data
(n = 91)

p-value

49.00 (6.34)

48.77 (4.84)

0.84

9.17 (8.49)

10.36 (9.07)

0.53

76.23 (24.63)

67.03 (26.58)

0.08

Parental marital status, n (%)
Currently married
Not currently married

23 (79.31)
6 (20.69)

76 (83.52)
15 (16.48)

0.60

Family income, n (%)
Less than $50,000
$50,000 - $99,999
$100,000 - $149,000
$150,000 or more

4
9
3
10

15
29
25
22

Parental age, mean (SD)
Parental depressive symptoms,
mean (SD)
Parental worry, mean (SD)

(15.38)
(34.62)
(11.54)
(38.46)

(16.48)
(31.87)
(27.47)
(24.18)

0.29

Family resources, mean (SD)

51.45 (10.36)

51.71 (12.39)

0.92

Family demands, mean (SD)

8.45 (5.19)

8.43 (6.11)

0.99

13.97 (3.22)

14.78 (4.19)

0.34

Family adaptation, mean (SD)
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